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ABSTRACT OF THE DISSERTATION
INDIVIDUAL LEVEL FACTORS ASSOCIATED WITH HIV CARE CONTINUUM
METRICS AMONG MASH COHORT PARTICIPANTS FROM 2009-2014
by
Kristopher Myers
Florida International University, 2019
Miami, Florida
Professor Kristopher Fennie, Major Professor
This dissertation assessed the following: 1) the individual-level factors’
individual, syndemic, and interactive associations with retention in HIV care; 2) the
individual-level factors’ individual, syndemic, and interactive associations with
adherence among retained persons; and 3) the individual-level factors’ individual,
syndemic, and interactive associations with viral suppression among retained persons.
In the first study, Non-Hispanic Black race/ethnicity was associated with
improved retention (OR=2.44, 95%CI: 1.06–5.75, p≤0.05). “Black-Hispanic” and
“Other” racial/ethnic identities were associated with increased retention among
participants (OR=4.84, 95%CI: 1.16–25.79, p≤0.05 and OR=7.24, 95%CI: 1.54–
54.05p≤0.05, respectively). The interaction between depressive symptoms and alcohol
use disorder was significantly and negatively associated with retention in HIV care
(OR=0.14, 95%CI: 0.01–1.11, p≤0.10). This negative interaction suggests that the
impact of depression on retention differs by alcohol use disorder (or equivalently the
impact of alcohol use disorder on retention differs by depression status). The interaction
between age and male gender was also negatively associated with retention (OR=0.95,
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95%CI: 0.88–1.01, p≤0.10). This suggests that the impact of male gender on retention
may be influenced by increased age (or equivalently the effect of age on retention varies
by male gender). The interaction between male gender and depression was positively
associated with retention (OR=7.17, 95%CI: 0.84–98.49, p≤0.10). Given our
understanding of previous literature, we interpreted this as the impact of depression on
retention in care is influenced by male gender. In the second study, we determined that
cocaine use was significantly and negatively associated with short term adherence when
compared to persons who tested negative for cocaine use (OR=0.23, 95%CI: 0.05–0.86,
p=0.05) when adjusting for all other factors. Education had a significant negative
association with long term adherence (OR=0.73, 95%CI: 0.57–0.91, p=0.01).
In the final study, among 51 retained persons with HIV we determined NonWhite race/ethnicity (OR=0.28, 95%CI: 0.05–1.12, p=0.09), education (OR=0.75, 0.52–
1.03, p=0.10), and male gender (OR=0.33, 95%CI: 0.09–1.05. p=0.07) were marginally
and negatively associated with viral suppression. Collectively, our study findings suggest
that multiple individual level factors individually and interactively have a deleterious
effect on multiple stages of the HIV care continuum.
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Background
In the United States, approximately 1.1 million persons were living with HIV
in 2016 (1). Among persons living with HIV, 40% were engaged in HIV medical
care, 37% were prescribed ART, and 30% achieved viral suppression (2). Persons
living with HIV who achieve viral suppression can have a nearly normal life
expectancy and develop a reduced risk for transmitting HIV to others (3,4). However,
every year in the United States, approximately 50,000 persons become infected with
HIV (5). Each step along the HIV care continuum (HIV retention in care and
adherence to ART) is essential for achieving a suppressed viral load (6). Reduced
engagement in HIV medical care has been associated with poor clinical outcomes
including reduced retention, poor antiretroviral adherence, virologic failure, and
mortality (7). Multiple individual-level factors have been associated with reduced
progression along the HIV care continuum (7). Recent literature indicates that to
mitigate losses of patient engagement at different stages of the continuum, it is
important to focus on individual–level factors at each stage of the continuum (8).
According to the behavioral model for vulnerable populations, individual-level
factors are stratified into the following categories: traditional factors, vulnerability
factors, and enabling factors (9). Traditional factors include demographic information
such as age, gender, and race/ethnicity. Vulnerability factors include factors such as
mental illness and substance abuse (9). Enabling factors are those that can impede or
enhance access to HIV care and include income, insurance, housing, and social
support (9).
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Recent literature has suggested that education is a socioeconomic
vulnerability factor; it was not originally considered such in the behavioral model for
vulnerable populations (10). Specific, individual-level factors that have been
suggested to impede progress to various stages of the HIV care continuum include
depressive symptoms, cocaine use, marijuana use, alcohol use, and cigarette use (1114). While there are studies assessing individual level traditional factors’ and
vulnerability factors’ association with progression to some stages of the HIV care
continuum, there are few assessing specific individual level traditional and
vulnerability factors’ association with progression throughout the full HIV care
continuum. Examining the association of specific individual level traditional and
vulnerability factors with progression from one stage to the next and determining
what individual-level vulnerability factors are associated with reduced progression
can provide valuable insight that can be utilized to determine targets for intervention.
The effect of multiple factors on HIV care continuum metrics is generally
assessed individually; however, these factors occur in concert with one another. One
type of association that may explain the multifaceted manner in which individuallevel characteristics are associated with retention is syndemic or additive association.
Syndemic theory, established by Merill Singer, involves a set of mutually enhancing
health problems that, working together in a context of harmful social and physical
conditions increase vulnerability, and significantly affect the overall disease status of
a population (15). Syndemic theory postulates that a constellation of health problems
accumulates over a person’s lifespan and can amplify the negative impact of one or
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more health problems (16). Determining syndemic or additive associations involves
determining the sum of multiple factors on a particular outcome (15). These
individual-level traditional and vulnerability factors may also be effect modifiers in
assessing retention. An interactive association among factors involves the
simultaneous, non-additive influence of two or more variables on an outcome (17).
Using the syndemic and interactive frameworks is an innovative way of examining
the association of individual-level traditional and vulnerability factors on retention in
care. Syndemic associations assess if variables in the behavioral model for vulnerable
populations work synergistically to impede progression to retention in care.
Identifying interactions determined to be significant may lead to conclusions
regarding which factors influence the relationship between independent variables and
progression to various stages in the HIV care continuum.
This dissertation aimed to determine the individual, syndemic, and interactive
associations of cocaine use, alcohol use disorder and depressive symptoms with
retention among a cohort of adults living with HIV/AIDS in Miami/Dade between
2009-2014. This dissertation further aimed to determine the individual, syndemic, and
interactive associations of cocaine use, alcohol use disorder, depressive symptoms,
with ART adherence among a cohort of adults living with HIV/AIDS who have been
retained in care in Miami/Dade between 2009-2014. Finally, this study aimed to
determine the individual, syndemic, and interactive associations of cocaine use,
cigarette smoking, alcohol use disorder, and depressive symptoms on viral

3

suppression among ART adherent adults living with HIV in Miami/Dade between
2009-2014 in MASH (Miami Adult Study on HIV/AIDS).
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Figure 1: The HIV care continuum. The model has been adapted by the
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Figure 2: The behavioral model for vulnerable populations. The model has
been adapted by the author, with reduced components that influence health
behaviors and outcomes. Adapted with from original model created by
Christopoulos et al. 2011(9).
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Literature Review
Depression and Depressive Symptoms
Although depression has not been studied as a precise variable that effects
progression throughout the entire continuum, there are studies that evaluate the
association between depression and progression to discrete stages of the HIV care
continuum.
In a study conducted by Zuniga and colleagues, researchers attempted to
determine the association of depressive symptoms with retention in care among
persons living with HIV. The study involved 204 persons who were recruited from
public hospital-affiliated outpatient HIV clinics in South Florida from August 2009 to
May 2011 (1). The majority of the population was African American (82.9%) and the
average for years of education was below the secondary or high school level
(11.1±2.1 years of education) (1). Researchers found that increased scores on the
somatic symptom scale were positively associated with reduced retention OR=1.604
(95%CI: 1.09,2.37 p= 0.0175) (1). The statistics suggest that as the somatic
symptoms suggestive of depression diagnosis increases, so do the odds of having at
least one four-month interval with a missed visit (1).
In another study conducted by Gonzalez and colleagues in 2011, they assessed
the association between depression and HAART adherence (2). Each unit increase on
the Clinical Global Depression Scale score was associated with a 75% increased odds
of nonadherence (OR=1.75, 95% CI=1.23–2.48, p=0.002) (2). Each unit increase on
the Montgomery Asberg Depression Rating Scale was associated with a 2.6-fold
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increase in the odds of HAART nonadherence (OR=2.60, 95% CI=1.45–4.67,
p=0.001). The outcome of the logistic regression that assessed the relationship
between scores on the Clinical Global Impression Scale for depression and adherence
suggests an association between symptoms suggestive of depression diagnosis and
adherence (2). The outcome of the logistic regression that assessed the relationship
between scores on the Montgomery Asberg Depression Rating scale and adherence
suggests an association between depression severity and reduced adherence.
In a study conducted by Carrico et al., they assessed the association between
depression and viral load. The results indicated that a higher number of symptoms of
depression at baseline predicted a 50% higher mean HIV viral load in the 25 months
following baseline (β=0.13, p<0.01); this suggests a relationship between depressive
symptoms and increased viral loads.
Current research suggests that symptoms suggestive of depression diagnosis
are associated with retention, adherence and viral load(1),(2),(3). There is currently no
research that assesses the association between depression and progression through the
entire HIV care continuum.

Cocaine
Although cocaine has not been directly studied as it relates to the HIV care
continuum, there have been studies assessing the association between cocaine usage
and progression to different individual stages of the HIV care continuum.
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Althoff and colleagues assessed the association between cocaine use and
retention among participants in a multisite study, which assesses jail-release
interventions at ten urban US sites. The study found that former inmates who reported
cocaine use within the last 30 days were 34% less likely to have visited an HIV
provider during days 91–180 after jail release. Cocaine was the only substance
significantly associated with reduced retention for this time period (4).
In another study conducted by Gonzalez and his colleagues, researchers
assessed the association of multiple drugs on antiretroviral therapy adherence among
121 HIV positive intravenous drug users who were currently receiving opioid
dependence treatment. Adherence was defined as the final percent of doses “taken ontime” over the 2-week period and monitored using the medication event monitoring
system (MEMS) caps for the ART medication (5). Researchers assessed substance
use within the past 30 days which included the following substances: opiates, cocaine,
sedatives, alcohol, marijuana, and multiple substances (two or more substances) (5).
In the analysis, only cocaine (β = −.22; p = .02) and multiple substance use (β =
−.22; p = .02) within the past 30 days were significantly related to decreased HIV
medication adherence (5). This indicates that cocaine is negatively associated with
ART adherence among HIV positive intravenous drug users (5).
The recent literature also suggests that injection cocaine use is associated with
reduced viral suppression. Kerr and colleagues prospectively observed 267 ART
naive patients (6). The researchers assessed the association between illicit drug use
and viral suppression. Viral suppression was defined as the first instance of achieving
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plasma HIV-1 RNA suppression of less than 500 copies/mL and assessed via
laboratory data (6). Drug use was determined at baseline in this study. Researchers
found that among exclusive cocaine injection users 57.6% (95%CI: 40.6%–75.6%)
attained viral suppression at 12 months, while 88.8% (95%CI: 76.2%–96.4%) of noninjecting persons attained viral suppression at 12 months (6). The Kaplan-Meier
analysis indicated the differences between these two groups was statistically
significant (p<0.01) (6).
Current research suggests that cocaine use is associated with reduced
retention, adherence, and viral suppression, however, there is no research on the
association between cocaine use and HIV testing(4),(5),(6). There is currently no
research that directly relates cocaine use with progression through the entire HIV care
continuum

Intravenous Drug Use
The literature reveals mixed findings relative to the association between
intravenous drug use and progression to the various stages of the HIV care
continuum. Recent literature suggests that a lower percentage of HIV infected persons
who engage in intravenous drug use progress to the stages of the HIV care continuum
when compared to all persons with HIV, specifically among Hispanic Americans,
African Americans, and a cohort constructed from 28 jurisdictions within the United
States (7-9). Some studies indicate no major percentage differences in progression
through the HIV care continuum between those who engage in intravenous drug use
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and the overall population with HIV. Researchers found that intravenous drug users
with HIV did not progress through the HIV care continuum at reduced percentages
when compared to the progression among HIV infected persons overall; this trend
was illustrated by a study conducted by the CDC, in which researchers used the
National HIV Surveillance System (NHSS) to estimate national progression through
the HIV care continuum (10). This trend of similar progression among both groups is
illustrated again using NHSS to estimate national progression through the HIV care
continuum among African Americans with HIV (11). While these studies indicate
percentage differences or similarities for progression through the HIV care
continuum’s various stages among intravenous drug users as compared to persons
with HIV overall, none yielded statistically significant findings.
In a study conducted by Lesko and colleagues using the Johns Hopkins HIV
Clinical Cohort (JHHCC), researchers assessed the association between injection drug
use on retention, antiretroviral therapy (ART) use, and viral suppression. The cohort
consisted of all HIV-infected persons age 18 years and older who enrolled in HIV
care at Johns Hopkins outpatient HIV clinic who agreed to share their data. Patients
who reported IDU as a likely source of their HIV infection when they registered into
care were classified as persons with injection drug use (PWID) (12). The researchers
first determined the crude proportion of participants that progressed to each stage in
the HIV care continuum and subsequently conducted a binomial logistic regression
for each step in the HIV care continuum. The researchers found that among persons
who injected drugs in 2010, 77.8% were retained in care, 69.3% were on ART, and

11

63.3% were virally suppressed. Among persons who did not engage in injection drug
use, 82.0% were retained in care, 74.8% were on antiretroviral therapy and 70.1%
were virally suppressed (12). Retention was defined as those with greater than or
equal to 2 clinic visits at least 90 days apart. ART use was defined as retained patients
with at least one ART prescription for more than 30 days between during the calendar
year (12). Viral suppression was defined as adherent patients with at least one HIV
viral load count ≤400 copies/mL between January 1 and December 31 of 2010 (12).
The researchers found a higher percentage of viral suppression and persons on
antiretroviral therapy among those who did not use injection drugs; there were no
levels of significance attached to these percentages. The researchers found in the
unadjusted analysis that intravenous drug use was associated with ART use RR=0.94
(95% CI: 0.89-0.99, p≤.05), retention RR= 0.96 (95% CI: 0.93-0.99, p≤.05), and viral
suppression RR=0.96 (95%CI: 0.93- 0.99, p≤.05) in 2010 (12). This indicates that
among the JHCC, those who used intravenous drugs were significantly less likely to
be retained in HIV care, on ART, or have achieved a state of viral suppression when
compared to those who do not engage in intravenous drug use. Other studies
corroborate these findings (13-15)
The current research provides mixed findings related to the association
between intravenous drug use and progression to the various stages of the HIV care
continuum. However, the literature suggests that among persons 18 years and older,
intravenous drug use is significantly associated with reduced retention in care,
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prescription of ART, and viral suppression, each a vital stage in the HIV care
continuum (12,16,17).

Marijuana
In a study conducted in Connecticut involving men who have sex with men,
researchers compared the HIV care continuum metrics between heavy marijuana
users and intermittent marijuana users. The sample is derived from the uConnect
cohort and consisted of 618 African American men who have sex with men (18).
When comparing never users to heavy users the researchers noted that heavy
marijuana users had 4.18 (95% CI: 1.26- 13.89, p<.05) times the odds of being
unaware of their HIV positive status than did those who never used drugs (18). The
odds ratios for progression to the other stages of the HIV care continuum were not
statistically significant. This study indicates that there is not a relationship between
marijuana smoking and progression through the various stages of the HIV care
continuum. This is currently the only study that assesses marijuana use directly with
progression through the HIV care continuum. However, there are other studies that
assess the association between marijuana use and progression to discrete stages of the
HIV care continuum.
In one study researchers assessed the association between marijuana use and
retention in HIV care using a retrospective cohort study design. The examined
population were patients at the Vanderbilt Comprehensive Care Clinic (VCCC) (19).
Marijuana use was defined as use at least one time in the past week on at least one
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screening questionnaire (19). Retention was defined as missed visits in 2012 (19).
The researchers found that any marijuana use within the past week was associated
with missing next scheduled clinical appointment, RR= 1.37 (95%CI: 1.12, 1.69,
p<0.05 (19). The association between smoking marijuana and missing the next
scheduled clinical appointment was highest among those who smoked marijuana
seven times per week, RR=1.67 (95% CI: 1.30, 2.15, p<0.05) (19). This study
suggests that smoking marijuana within the past week is associated with an increased
risk of reduced retention.
In another study, researchers assessed the association between marijuana use
and adherence to HAART medication. Researchers separated cannabis users into
three groups non-cannabis users, cannabis users, and cannabis dependent users (20).
Using the ANOVA analysis researchers found that non-cannabis users (0.97±0.09)
had a significantly higher mean adherence (0.93±0.15) than did cannabis users for the
four days prior to the examination (F=3.26, p<0.05) (20). The study implies that
cannabis use is associated with reduced adherence to antiretroviral medication.
Another study assessed the association between marijuana use and viral
suppression. Sinha and colleagues examined data from the Johns Hopkins HIV
Clinical Cohort (JHHCC). Marijuana use was divided into the following categories:
1) no lifetime use, 2) past use, but none in the past 3 months, 3) monthly or less and
4) weekly or daily/almost daily (21). Researchers assessed viral suppression using
laboratory records; viral suppression was defined as an HIV-1 RNA ≤200 copies/mL.
HIV-1 RNAs (21). Researchers determined that having not used marijuana within the
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last three months was associated with an increased odds of attaining an undetectable
viral load OR=1.45 (95%CI: 1.07–1.96, p<0.05) (21). This study suggests that not
using marijuana within the last three months is associated with a greater likelihood of
attaining an undetectable viral load.
Although there is scarce literature that relates marijuana use directly to the
HIV care continuum, the literature does suggest an association between marijuana use
and the multiple stages of the HIV care continuum (retention, adherence, and viral
suppression) (19),(20),(21).

Alcohol
Although alcohol use has not been directly studied as it relates to the HIV care
continuum, the literature does illustrate that alcohol use is associated with reduced
progression to various stages in the HIV care continuum. The majority of studies
relating alcohol to HIV care primarily focus on two stages of the HIV care
continuum: adherence and viral suppression.
The current literature suggests that studies have noted alcohol use to be
negatively associated with multiple stages of the HIV care continuum including:
testing, care retention, ART adherence, and viral suppression (22-25). There were few
studies that linked alcohol abuse to HIV testing included in the literature that were
conducted in the United States.
In a study conducted by Frimpong and colleagues, the researchers examined
the correlates of HIV testing. Data from this study are derived from the Los Angeles

15

County Participant Reporting System (LACPRS). The researchers used the GelbergAnderson Behavioral Model for Vulnerable Populations to develop independent
variables that may be associated with HIV testing. The model explains the
relationships among predisposing, enabling, and need factors that alter health services
utilization in the general population (22). Researchers first conducted a chi-squared
test and found that alcohol was significantly associated with HIV testing (p<0.01),
(22).
In a study conducted by Chitsaz and colleagues, researchers attempted to
assess the effect of multiple factors on progression through the HIV care continuum
among HIV positive prisoners. Alcohol use in the 30 days pre-incarceration was the
definition of alcohol use in this study. Linkage was defined as having an HIV care
provider in the 30 days prior to incarceration (26). Linkage was not found to be
associated with ASI (Addiction Severity Index) alcohol composite score;
OR=0.67(95%CI: 0.34-1.31, p=0.238) (26). Other studies in the literature corroborate
these findings (4).
The relationship between alcohol use and retention in care has been firmly
established by the literature. A study conducted by Cunningham et al. assessed the
relationship between alcohol use and retention. Retention was defined as two or
more medical visits in the prior 6 months, as this is an established indicator of poor
HIV care (23). Heavy alcohol use was defined as drinking five or more drinks of
alcohol in one day within the last thirty days (23) The researchers found heavy
alcohol use is significantly associated with reduced HIV care visits AOR=1.74 (95%
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CI: 1.23-2.45, p<0.05) (23). This indicates that heavy alcohol use is significantly
associated with poor retention.
The literature also establishes a significant association between alcohol use
and ART adherence among HIV infected individuals. Rosen and his colleagues
conducted a cross sectional study to determine the relationship between alcohol and
ART adherence. To develop a measure that could be extracted from different
questions asked at different sites, alcohol use was standardized across sites as the
percentage of measured days having used alcohol. Adherence was measured by
dividing the total number of openings by the number of prescribed doses for each
medication. Alcohol use was determined to be negatively and independently
associated with reduced ART adherence. Rosen and his colleagues noted that alcohol
use (β=-0.04, p<.05) and the number of days alcohol was used (β=-0.097, p<.05)
were both significantly associated with lower adherence (24).
The literature suggests an association between alcohol use and an increased
viral load. Wu and colleagues examined the relationship between alcohol use and
viral load, independent of adherence to HAART (25). Participant alcohol use was
categorized by four response options: every day, a few times a week, a few times a
month, and not at all (25). The linear regression, which was adjusted for adherence
and demographic covariates, indicated that daily drinkers had nearly a four-fold
increase in the odds of detectable viral load OR=3.81 (95%CI: 1.42- 11.48,
p=0.01)(25).
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Alcohol has been assessed as a factor that is associated with multiple HIV
care continuum metrics. The literature indicates that alcohol use is associated with
reduced retention, decreased adherence, and an increase in the odds of acquiring a
detectable viral load (22-25), (26).

Cigarette smoking
There is currently a lack of literature that relates cigarette smoking directly to
the HIV care continuum. Individual stages of the HIV continuum have been studied
as they relate to cigarette smoking, the majority of these studies are related to
adherence and viral suppression.
In one study researchers attempted to determine the relationship between
smoking and adherence to HAART. Adherence was defined as (number of bottle
openings/number of prescribed doses of lopinavir/ritonavir) x 100 (27). Adherence
was monitored using the Medication Event Monitoring System (MEMS). Researchers
noticed that smokers took 65% (SE=22.1) of prescribed doses while non-smokers
took 84.8% (SE=15.8) (27). These percentages were statistically significant indicating
that adherence to ART is less prevalent among cigarette smokers. Researchers, using
a multiple linear regression model, found that being a current cigarette smoker is
independently associated with poorer ART adherence (p<0.001) (27).
Viral suppression, while not indicated to be directly affected by smoking was
shown to affect T-cell viability. A T-cell’s function is to lyse virally infected cells; an
inhibition of this function may cause an increase in viral load (28). In one study
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researchers attempted to determine whether T-cell functions, such as the defense
against infectious agents, could be altered by the exposure to cigarette smoke extract.
Smoke from two Kentucky research cigarettes without filters, 1R4F containing 11 mg
tar and 0.8 mg nicotine, was bubbled through 50 ml of cell culture medium at a speed
of 5 min per cigarette (28). T-cells were isolated by gradient centrifugation on FicollPaque (28). T-cell viability was determined by activation (CD25 expression). CD25 is
a transmembrane protein present on all active T-cells (28). Researchers found cells
that were exposed to cigarette smoke extract or CSE had a viability of 69%, while
those not exposed had a viability of 76% and both percentages were statistically
significant (28). This indicates that T-cells’ viability is affected by cigarette smoke
exposure and may ultimately lead to an increase in HIV viremia. This study, which
utilized data on CD25 expression as a proxy for cell activation after its exposure to
CSE, is the first of its kind. This is a relatively new topic of study and more research
is necessary to better explain the exact mechanism causing the association between
CSE exposure and T cell viability.
Although cigarette use has not been directly studied as it relates to the HIV
care continuum, it has been assessed as a factor that is associated with multiple HIV
care continuum stages. The literature indicates that cigarette use is associated with
reduced adherence and a reduction in T-cell viability which may affect viral
load(27),(28).
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Conclusion
Current research suggests that intravenous drug use is significantly and
negatively associated with nearly each stage in the HIV care continuum (16). The
literature also implies that smoking marijuana is negatively associated with retention
and adherence, however, abstinence from marijuana use is positively associated with
reduced viral load(19),(20), (21). Alcohol use, although not directly studied, is
illustrated to be negatively associated with retention, adherence, and viral suppression
(23-25). Cigarette smoking has not been directly studied as an independent variable
related to the HIV care continuum, however recent literature suggests that smoking is
negatively associated with adherence and viral suppression (27,28). Scarce literature
exists relating cigarette smoking, alcohol abuse, marijuana use, and cocaine use
directly to the HIV care continuum; this is important as cigarette smoking, alcohol
abuse, marijuana use, and cocaine use are highly prevalent behaviors among persons
with HIV (29-31). These behaviors may be related to other characteristics of persons
with HIV, however, there is a gap in the literature, as there is scarce research directly
associating substance use (illicit or legal) in concert with other factors to the
progression along the continuum. Another limitation of the majority of these studies
is that they do not assess the effect of factors (cigarette smoking, alcohol abuse,
marijuana use, and cocaine use) throughout the entire continuum; my study will
address this limitation by assessing the effect of these factors throughout the entire
continuum. Determining relationships among factors associated with this reduced
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progression will provide information that can inform more specific interventions and
provide information that can aid prioritization for interventions.
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© Copyright 2019
The Individual, Interactive, and Syndemic Effect of Substance Use, Depression,
Education, and Race/Ethnicity on Retention in HIV Care Among MASH Cohort
Participants from 2009-2014.

Abstract
Objectives: In this study, we sought to assess the individual-level factors’ individual,
syndemic, and interactive associations with retention in care. Design: The sample
was derived from the Miami Adult Studies on HIV/AIDS (MASH) cohort study from
2009-2014. The variables were entered into a multiple logistic regression with
retention as the outcome to determine which factors were significantly associated
with retention. Backward regression, adjusting for all main effects was conducted, to
determine which two-way interactions were associated with retention. Multivariable
logistic regression was used determine whether number of factors were associated
with retention. Results: Non-Hispanic Black race/ethnicity was associated with
improved retention (OR=2.44, 95%CI: 1.06–5.75, p≤0.05). “Black-Hispanic” and
“Other” ethnic identities were associated with increased retention among participants
(OR=4.84, 95%CI: 1.16–25.79, p≤0.05 and OR=7.24, 95%CI: 1.54–54.05p≤0.05,
respectively). The interaction between depressive symptoms and alcohol use disorder
was significantly and negatively associated with retention in HIV care (OR=0.14,
95%CI: 0.01–1.11, p≤0.10). The interaction between age and male gender was also
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negatively associated with retention (OR=0.95, 95%CI: 0.88–1.01, p≤0.10), and the
interaction between male gender and depression was positively associated with
retention (OR=7.17, 95%CI: 0.84–98.49, p≤0.10). Conclusion: Multiple
race/ethnicities are associated with improved retention. Multiple factors interact to
alter retention in HIV care.
Key words: Epidemiology, HIV, Antiretroviral Therapy

Introduction
Reduced engagement in HIV medical care has been associated with poor
clinical outcomes including reduced retention, virologic failure, and mortality(1).
Multiple individual-level factors have been associated with reduced progression along
the HIV care continuum (1). Recent literature indicates that to mitigate losses of
patient engagement at different stages of the continuum, it is highly important to
focus on the individual-level factors at each stage of the continuum (2). According to
the behavioral model for vulnerable populations, individual-level factors are stratified
into the following categories: traditional factors, vulnerability factors, and enabling
factors (3). Traditional factors include demographic information such as age, gender,
and race/ethnicity. Vulnerability factors include factors such as mental illness and
substance abuse (3). Enabling factors are those that can impede or enhance access to
HIV care and include income, insurance, housing, and social support (3). Specific,
individual-level factors that have been suggested to impede progress to retention
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include having less than a high school education, depressive symptoms, cocaine use,
marijuana use, and alcohol use (4-7).
Retention is a pivotal component of the HIV care continuum. According to
recent literature, retention is defined as two or more HIV-related physician visits or
diagnostic tests (CD4 count or viral load tests) in the calendar year at least three
months apart (8,9). Recent literature suggests that individual-level traditional,
enabling, and vulnerability factors are each associated with retention in HIV care
(5,10,11). The effect of multiple factors on retention is generally assessed
individually; however, these factors occur in concert with one another. One type of
association that may explain the multifaceted manner in which individual-level
characteristics are associated with retention is syndemic or additive association.
Syndemic theory, established by Merill Singer, involves a set of mutually
enhancing health problems that, working together in a context of harmful social and
physical conditions increase vulnerability, and significantly affect the overall disease
status of a population (12). Syndemic theory postulates that a constellation of health
problems accumulates over a person’s lifespan and can amplify the negative impact
of one or more health problems (13). Determining syndemic or additive associations
involves determining the sum of multiple factors on a particular outcome (12). These
individual-level factors may also be effect modifiers in assessing retention. An
interactive association among factors involves the simultaneous, non-additive
influence of two or more variables on an outcome (14). Using the syndemic and
interactive frameworks is an innovative way of examining the association of
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individual-level factors on retention in care. Syndemic associations assess if variables
in the behavioral model for vulnerable populations work synergistically to impede
progression to retention in care. Identifying syndemic associations may provide
further evidence of the synergistic effect of individual-level factors on retention in
HIV care. Identifying interactions determined to be significant may lead to
conclusions regarding which factors influence the relationship between independent
variables and progression to retention in HIV care.
In this study, we sought to assess the association of individual-level factors’
individual, syndemic, and interactive associations with retention in care. The
syndemic and interactive approaches of assessing multiple factors within a population
are important for the development of future interventions targeting retention, as a
person with HIV is multidimensional and may need more than a single, unimodal
intervention.

Materials and Methods
Setting and Population
The sample was derived from the Miami Adult Studies on HIV/AIDS
(MASH) cohort study. Further details related to the methodology of the original
project can be found in a paper entitled, “Cocaine Use and Liver Disease are
Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH)
Cohort” (15). This is a secondary analysis of a prospective cohort study involving 407
HIV positive individuals residing in the south Florida region. Participants were a
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subset of the more than 800 participants from the MASH cohort who have been
followed from 2009 - 2014. All independent variables were assessed at baseline and
participants were subsequently followed for a one-year period after baseline to
determine retention status. All participants provided written consent to participate in
the original study (MASH Cohort Study) consistent with the Florida International
University Institutional Review Board IRB: 13-0038.

Eligibility Criteria
Participants were eligible to participate if they were (1) eighteen years of age
or older, (2) diagnosed with HIV by a standardized testing method, (3) participated in
the study from 2009-2014, (4) provided informed consent, (5) and had complete data
at baseline.

Measures
The primary outcome of this study was retention in care, defined as two or
more HIV-related physician visits or diagnostic tests (CD4 count or viral load tests)
during the calendar year at least three months apart (8,9). Those who met this
criterion were considered “retained”, those who did not, were codified as “not
retained”. Demographic measures such as age, race/ethnicity, gender, and educational
attainment were determined using tools from the Tier 1 Phen X Toolkit designed for
NIH clinical trials at the screening phase of the study (16,17). Age, race/ethnicity, and
gender were determined using the validated “Current Age, Gender, and Race
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Questionnaire” survey from the Tier 1 Phen X Toolkit (16). Education was
determined using the validated “Current Educational Attainment Questionnaire” from
the Tier 1 Phen X Toolkit (16).
Age was determined in the MASH survey through self-report and calculated
from the year of birth. Age was categorized in the current study as follows: “≤ 25”,
“26-34”, “35-44”, and “≥45”, for the purpose of assessing frequencies among age
groups (18). However, age was assessed as a continuous variable in all logistic
regressions (19). Race/ethnicity was assessed via self-report and was categorized as:
“White (Non-Hispanic)”, “Black (Non-Hispanic)”, “Hispanic”, “Asian”, and “Other”
(20). Gender was defined as a categorical variable including: “Males”, “Females”,
“Transgender”, and “Declined” (21). Education was assessed via self-report. In the
current study, educational attainment was assessed using the following categories:
“Less than high school education”, “High school graduate or equivalent”, and “More
than high school education” for the purpose of assessing the frequencies of
educational attainment of the population (22). However, in the logistic regressions
education was assessed as a continuous variable (23).
In the MASH cohort study, the validated Center for Epidemiologic Studies
Depression Scale (CES-D) was used to assess depression at baseline (24). A score of
16 or higher indicated symptoms suggestive of clinical depression diagnosis, while
scores of 15 and below indicated that persons did not have symptoms suggestive of
clinical depression diagnosis (25). This variable was coded dichotomously:
“Depressed” and “Not Depressed” (25).
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Cocaine use and marijuana use were assessed using the Multi-Drug 5 Panel
Urine Dip Test Kit (WDOA-754). This test allowed researchers to assess drug use in
the past three days. This testing method has been approved by the FDA (26). Cocaine
and marijuana use within the past three days were each categorized dichotomously
(positive or negative). Alcohol use disorder was determined from the Alcohol Use
Disorder Identification Test (AUDIT) at baseline; this form has been validated by
Saunders and colleagues (27). This is a 10-item scale in which each question is worth
one point. A score of 8 or more is considered indicates symptoms suggestive of
alcohol use disorder. Alcohol use disorder was categorized as a dichotomous
variable, either as “having alcohol use disorder” or “not having alcohol use disorder
(27).

Analysis
First, frequency distributions were examined for the variables (age,
race/ethnicity, education, substance use status, and retention status). The bivariate
association between these variables and retention was determined using a chi-square
test of independence. These variables were subsequently entered into a multiple
logistic regression with retention as the outcome to determine which individual-level
factors were significantly associated with retention. After determining the individuallevel factors associated with retention, all two-way interactions among these factors
were included in the logistic regression. Subsequently, backward regression,
adjusting for all main effects was conducted, to determine which two-way
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interactions were associated with retention. All interactions with p≤0.10 were
included in the final model (28). The threshold of p≤0.10 was used to determine the
exclusion of interactions as the sample size was relatively small and 0.05 would be
highly exclusive to interactions of interest (29). To explore the relationship between
significant interactive variables and retention, stratified logistic regressions were
performed among variables with significant interaction terms. To determine the
syndemic or additive association between independent factors and retention,
researchers developed a count score of the number of individual-level factors (from 0
to 5).
All variables were categorized dichotomously, whereby a score of five
indicates that all factors are present, while a score of zero indicates that none of the
factors is present (30). For the purpose of the syndemic analysis, all independent
variables not already dichotomous were collapsed into dichotomous variables (30).
Education was reduced to two categories (“graduated high school” and “did not
graduate high school”) (30). Mantel-Haenszel chi-square method was used to test for
the association between the number of individual-level factors and retention within
the sample. A multivariable logistic regression model was used to determine if
number of individual-level factors was associated with retention (30). Odds ratios
were reported at 95% confidence intervals to estimate the effect of each variable.
Interactions were reported at 90% confidence intervals to estimate the effect of each
variable. All statistical analyses were performed using R Version 3.4.1.
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Results
A subsample of 407 MASH participants were eligible for this analysis. Table
1 summarizes retention frequencies of participants in the sample as well as their
demographic characteristics. Overall, 267 (65.6%) of the HIV infected participants
were retained in HIV care, while 140 (34.4%) were not retained. The majority of
participants were Non-Hispanic Black persons (n=278, 68.5%). The sample was
predominately male (n=263, 65.2%). The majority of persons were 35 years of age or
older (n=371, 91.2%). In Table 1, we also present the outcome of the bivariate
association between the variables and retention. There were no significant
associations.
Table 2 presents model 1 and model 2. In model 1 we summarize results of a
logistic regression, that assessed the association between all variables (excluding the
interaction terms) and retention in HIV care. Model 1 indicates that race/ethnicity had
a significant association with retention. The results suggested that Non-Hispanic
Black race/ethnicity was associated with improved retention (OR=2.44, 95%CI: 1.06–
5.75, p=0.04). Model 1 also indicates that both “Black-Hispanic” and “Other”
racial/ethnic identities were associated with increased retention among participants
(OR=4.84, 95%CI: 1.16–25.79, p=0.04 and OR=7.24, 95%CI: 1.54–54.05p=0.02,
respectively). White-Hispanic race/ethnicity was not significantly associated with
retention in HIV care (OR=1.75, 95%CI: 0.68–4.57, p=0.24). All races/ethnicities
were compared to the White Non-Hispanic referent group. Marijuana use, cocaine use
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and other demographic factors (education, age, and male gender) were not associated
with retention.
Model 2 summarizes the final results of the backward regression which
included all single variables and two-way interactions that had a p-value ≤0.10. The
interaction between depressive symptoms and alcohol use disorder was significantly
and negatively associated with retention in HIV care (OR=0.14, 95%CI: 0.01–1.11,
p=0.08). The interaction between age and male gender was also negatively associated
with retention (OR=0.95, 95%CI: 0.88–1.01, p=0.10), and the interaction between
male gender and depression was positively associated with retention (OR=7.17,
95%CI: 0.84–98.49, p=0.10).
Table 3 presents the outcomes for all stratified analysis (models 3-6). The
stratified analysis indicated that among those who tested positive for depression, NonHispanic Black race/ethnicity was associated with retention (OR=2.36, 95%CI: 1.02–
5.52, p=0.05) (Model 3). Black-Hispanic race/ethnicity and Other race/ethnicity were
also associated with retention when compared to their White Non-Hispanic
counterparts (OR=5.99, 95%CI: 1.25–44.70, p≤0.04 and OR=6.82, 95%CI: 1.45–
50.40, p≤0.03) (model 3). Among those who were not depressed, we found no
significant association (model 4). Among males, depression was determined to be
positively associated with retention (OR=2.77,95%CI: 1.06–7.46, p=0.04) (model 4).
Among females, no variables were determined to be significant (model 5).
“In the syndemic analysis, we determined that 35.14% (n=143) of the
participants had two individual-level factors (Table 4). Approximately 31.20%
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(n=127) of participants had three factors (Table 4). The ‘four factors’ category
contained 12.03% (n=49) of the participants in the sample (Table 4). The ‘five
factors’ category included 1.97% (n=8) of the sample (Table 4). The ‘zero factor
category’ contained 0.98% (n=4) of the sample (Table 4). Of the 407 participants, 19
were not included in this section of the analysis due to missing values for one of the
factors.”. The bivariate association between the number of factors and retention
yielded no significant results, nor did the remainder of the syndemic analyses (Tables
4 and 5).

Discussion
While multiple races/ethnicities were associated with improved odds of
retention, persons in the Black Non-Hispanic racial/ethnic group had the lowest
magnitude of improved odds of retention. The data support previous literature which
suggests that Black Non-Hispanic race/ethnicity is associated with a reduced
magnitude of improved odds of retention when compared to other racial/ethnic
groups (10). A clinical implication of this finding would be to provide retention
counseling to Non-Hispanic Black persons who have been recently diagnosed. The
study also provides evidence that Black Hispanic persons and persons of the Other
race/ethnic groups have a higher odds of retention in HIV care than their NonHispanic White counterparts. Current literature supports the finding that Hispanic
persons have higher odds of being retained than do Non-Hispanic Blacks or NonHispanic Whites (5). There is scarce literature assessing the association of Black
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Hispanic race/ethnicity with retention, most literature typically assesses the
relationship between general Hispanic ethnicity and retention. More research is
necessary to determine the specific factors that contribute to this racial/ethnic group’s
improved retention. Literature indicates that persons of “Multiple” races/ethnicities
have a greater likelihood of achieving retention than do White Non-Hispanic HIV
infected persons; which may explain the “Other” racial category’s higher association
with retention. (31).
The interaction between depression and alcohol use disorder was
negatively associated with retention. This negative interaction suggests that the
impact of depression on retention differs by alcohol use disorder (or equivalently the
impact of alcohol use disorder on retention differs by depression status). Specifically,
this finding suggests that the impact of depression on retention in HIV care increases
as alcohol use disorder is present (or conversely the impact of alcohol use disorder on
retention in HIV is altered if depression is also present). While the literature suggests
that depressive symptoms and alcohol abuse reduce retention in HIV care separately,
this is the first paper to assess the effect of a two-way interaction between the two
variables on retention (4,32). Alcohol has been determined to exacerbate the effect of
depression among persons with HIV and increased depressive symptoms have been
shown to reduce retention (4,33). In addition, those who abuse alcohol are at
increased risk for major depression, and depression is associated with reduced
retention (4,34). Recent research related to the direction of causality between alcohol
use and depressive symptoms provides inconsistent results (34,35). A clinical
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implication of this finding would be to provide depressed HIV positive persons with
counseling regarding alcohol use. Another clinical implication may be to screen
persons with HIV who have alcohol use disorder for depression during HIV-related
visits.
The interaction between age and male gender is also negatively associated
with retention. The literature supports the notion that both male gender and increased
age reduce retention in care (36,37). This suggests that the impact of male gender on
retention may be influenced by increased age (or equivalently the effect of age on
retention varies by male gender). Specifically, this finding suggests that the impact of
male gender on retention in HIV care is altered as age increases (or conversely the
impact of increased age on retention in HIV is altered if male gender is also present).
A clinical implication of this finding would possibly be to provide retention related
counseling to HIV positive males, specifically among older men, during their initial
visit. The interaction between depression and male gender yielded a positive
association with retention. While both male gender and depression have been
indicated to reduce retention in care among HIV positive persons, some studies
indicate that there may be a higher odds of retention among males when compared to
females (4,5,38). Given our understanding of previous literature, we interpreted this
as the impact of depression on retention in care is improved if male gender is also
present(4,5). A clinical implication of this finding would be to provide HIV infected
women who are depressed with additional counseling and follow-up regarding HIVrelated visits during their initial visit.

37

To better understand the interactive effects, we conducted stratified analysis
which indicated that among those who are depressed, Non-Hispanic Blacks had an
increased odds of retention when compared to Non-Hispanic White persons, however,
the magnitude of increased odds of retention was larger among other racial/ethnic
groups (Black-Hispanic persons and Other persons). This trend is consistent with the
current literature (5,31). The reduced magnitude of the association of Non-Hispanic
Black race/ethnicity with retention may be related to stigma within the Black
community related to HIV care (39). A clinical implication of this finding may be to
increase efforts to improve retention among Non-Hispanic Black persons with HIV.
The increased retention among the Black Hispanic and other racial/ethnic groups may
be the result of specialized care in the Miami-Dade location. Previous literature
suggests that bilingual personnel in an HIV care facility increases clinical visits
among Hispanic persons with HIV (40). Given the large Hispanic population in
Miami, bilingualism is prevalent in most healthcare institutions.
Among males, depression was significantly associated with retention. A
positive association between depression and retention in HIV care is presented in the
literature, however, a majority of literature does indicate that depressive symptoms
are generally negatively associated with retention(4,32). This relationship has not
been assessed among an exclusively male group prior to this manuscript (32). Among
females, there were no significant associations. Due to the small sample size of nondepressed persons (n=29), we conducted a stepwise regression to reduce overfitting
the model by eliminating non-significant parameters (41). Gender was removed from
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this particular regression as there were only seven women in this subsample, none of
whom tested positive for alcohol use disorder in the non-retained group; which
resulted in zero value for one of the cells. Also, among women, none of the cells had
over five persons. For most multiple logistic regressions to function, no cells should
be zero and at least 80% should be greater than 5, this was not the case when crosstabulating female gender with alcohol use disorder (42). For the reasons mentioned
above the inclusion of gender in the logistic regression that assessed variables’
association with retention among the non-depressed would have been inappropriate.
Among the non-depressed, there were no significant associations with retention. This
model was from the manuscript as it provided no additional information regarding
associations among non-depressed persons.
A major strength of this study was a diverse group of HIV infected persons
from the Miami-Dade area including Hispanics and Blacks; two groups most affected
by HIV in the United States. Despite the strengths of this study, there were
limitations. One of the major limitations was a relatively small sample size for these
types of analyses, likely contributing to the wide confidence intervals related to some
of the point estimates. The small sample size limited the statistical power of the
syndemic analysis, which may have contributed to no significant findings.

Conclusion
Overall we found multiple racial/ethnic groups, multiple levels of a traditional factor,
are associated with improved retention and also multiple factors interact to alter
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retention in HIV care. This trend of ethnic disparities in retention persists among
depressed persons living with HIV in this study. This is important because these
findings suggest discrepancies among different race/ethnic groups related to retention
and clinical practices should be implemented to reduce these discrepancies. We also
determined that interactions depression*alcohol use disorder and male gender*age
can interact to reduce the likelihood of retention. This is important as barriers that
may reduce retention in HIV are not unimodal and can inform clinical practices. The
syndemic analysis revealed that most persons who were retained in care had two or
three factors that could reduce retention in care. This is also important as it can
influence clinical practice to assess patients for more than one factor when attempting
to identify factors that may negatively affect persons living with HIV.
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Tables

Table 1: Frequency of Demographic Characteristics and Drug
Use Among a Subsample of the MASH Cohort in Miami-Dade
County from 2009-2014
Variable

Race/Ethnicity
White
White
(Hispanic)
Black
Black
(Hispanic)
Other
Missing
Gender
Male
Female
Missing
Age
≤25
26-34
35-44
≥45
Missing
Education
<HS
HS
>HS

Retained
(n=267,
65.60%)
n (row %)

Not Retained (n
=140, 34.40%)

14 (50.00%)

14 (50.00%)

42(59.15%)

29(40.85%)

187(67.27%)

91(32.73%)

12(80.00%)

3(20.00%)

12(85.71%)

2 (14.29%)

172(65.40%)
91(65.00%)

5(83.33%)
19 (67.86%)
76(66.09%)
165(64.45%)

92(68.15%)
121 (66.12%)
49 (60.49%)

145(63.88%)
119(67.61%)

67 (68.37%)
194 (64.67%)

X², p-value

1(0.25%)

8.57, 0.07

4(0.98%)

0.00, 0.99

2(0.49%)

1.05, 0.79

8
(1.97%)

1.35, 0.51

4(0.98%)

0.46, 0.50

9(2.21%)

0.30, 0.58

n (row %)

91(34.60%)
49(35.00%)

1(16.67%)
9(32.14%)
39 (33.91%)
91 (35.55%)

43(33.85%)
62 (33.88%)
32 (39.51%)

Missing
AUDIT score
<8
≥8
Missing
Cocaine Use
Positive
Negative
Missing

Missing

82 (36.12%)
57 (32.39%)

31 (31.63%)
106 (35.33%)

45

Marijuana
Use
Positive
Negative

51(58.62%)
210(67.31%)

36(41.38%)
102 (32.69%)
8
(1.97%)

Missing

Depression
Positive (CES251(66.40%)
127 (33.60%)
D score ≥16)
Negative
(CES-D score
16(55.17%)
13 (44.83%)
<16)
Missing
0(0.00%)
Chi squared estimates do not include missing observations
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1.05, 0.21

0.31

Table 2: Adjusted Odds Ratio (AOR) for
Retention Among the MASH Cohort Participants
in Miami-Dade, FL from 2009-2014
Variable
AOR
Depression
CES-D Score <15
1.00
CES-D Score ≥16
0.53
Marijuana Use
Marijuana Use (-)
1.00
Marijuana Use (+)
0.73
Alcohol Abuse
AUDIT Score<8
1.00
AUDIT Score≥8
1.17
Cocaine Use
Cocaine (-)
1.00
Cocaine (+)
1.15
Education (yrs)
Education
0.91
Age (yrs)
Age
0.98
Race/Ethnicity
White (Non-Hispanic)
1.00
White (Hispanic)
1.75
Black (Non-Hispanic)
2.44**
Black (Hispanic)
4.84**
Other
7.24**
Gender
Female
1.00
Male
0.88
Two-Way Interactions
Depression x Audit
Depression x Gender
Age x Gender
**p-value≤0.05, *p≤0.10
AOR means adjusted odds ratio

Model 1
95%CI

AOR

Model 2
95%CI

0.84–4.31

1.00
1.20

0.15–6.88

0.43–1.27

1.00
0.69

0.40–11.21

0.74–1.85

1.00
7.39

1.22–68.03

0.68–1.95

1.00
1.18

0.69–2.05

0.82–1.01

0.90

0.81–1.00

0.96–1.01

1.02

0.97–1.08

0.68–4.57
1.06–5.75
1.16–25.79
1.54–54.05

1.00
1.56
2.25
5.37**
6.17**

0.61–4.14
0.98–5.31
1.23–29.96
1.34–47.94

0.55–1.39

1.00
1.72

0.34–76.70

0.14*
7.17*
0.95*

0.01–1.11
0.84–98.49
0.88–1.01
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Table 3: Adjusted Odds Ratios for Retention Stratified by CES-D Score and
Gender from 2009-2014

Variable
Marijuana
Use
Marijuana Use
(-)
Marijuana Use
(+)
Alcohol Abuse
AUDIT
Score<8
AUDIT
Score≥8
Cocaine Use
Cocaine (-)
Cocaine(+)
Education
(yrs)
Education
Age (yrs)
Age
Race/Ethnicity
White (NonHispanic)
White
(Hispanic)
Black (NonHisp.)
Black
(Hispanic)
Other
Gender
Female
Male

Stratified By Depression
Model 3 (CES-D Score ≥16)
AOR
95%CI

1.00
0.69

0.39–1.22

1.00
1.00

0.64—1.65

1.00
1.11

0.64–1.95

0.92

0.83–1.01

0.98

0.95–1.01

1.00
1.67

0.64–4.39

2.36**

1.02–5.52

5.99**

1.25–44.70

6.82**

1.45–50.40

1.00
0.98

0.95–1.01
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Stratified by Gender
Model 4 (Male)
AOR
95%CI
Depression
CES-D Score
<15
CES-D Score
≥16
Marijuana
Use
Marijuana Use
(-)
Marijuana Use
(+)
Alcohol Abuse
AUDIT
Score<8
AUDIT
Score≥8
Cocaine Use
Cocaine (-)

1.00
2.77**

1.00
1.06–7.46

1.00
0.72

0.83

0.11–
4.31

1.00
0.36–1.46

1.00
1.2

Model 5 (Female)
AOR
95%CI

0.66

0.27–
1.67

1.00
0.69–1.54x10³

1.00

1.22

0.53–
2.89

1.00

Cocaine (+)
Education
(yrs)

1.15

0.61–2.24

1.22

0.45–
3.49

Education
Age (yrs)

0.90

0.79–1.00

0.93

0.76–
1.13

Age
Race/Ethnicity
White (Non-Hispanic)
White
(Hispanic)
Black (NonHispanic)
Black
(Hispanic)
Other

0.97

0.93–1.00

1.02

0.97–
1.08

1.65

0.47–5.87

1.40

0.51

0.63–6.30

3.00

5.47

0.89–47.94

3.97

4.48

0.75–37.71

1.92x10⁷

**p-value≤0.05, *p≤0.10
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0.30–
7.10
0.81–
11.82
0.35–
99.48
0–N/A

Table 4 Frequency Distribution of Factors Among Retained and Not Retained in
the
MASH Cohort in Miami-Dade County from 2009-2012

Number
of
Factors

(4-Day Adherence)
Frequency (%) of category
Frequency (%) of
among retained
category among
non-retained

Zero

1(0.24%)

3(0.74)

One
Two
Three
Four
Five
Missing

41 (10.07%)
92 (22.61%)
83 (20.39%)
33 (8.11%)
5 (1.23%)
12 (2.95%)

16 (3.93%)
51 (12.53%)
44 (10.81%)
16 (3.93%)
3 (0.74%)
7 (1.72%)
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Total Frequency
(%) overall
4 (0.98%)
57 (14.00%)
143 (35.14%)
127 (31.20%)
49 (12.04%)
8 (1.97%)
19 (4.67%)

Table 5: Adjusted Odds Ratio for the Syndemic Association with Retention
(Model 6)
Variable
Number of Factors
Age
WH
Black
BH
Other
Male Gender

Exp (Est.)

Exp (CI)

0.99

0.79-1.24

0.98
1.7
2.51**

0.96-1.01
0.68-4.39
1.09-5.87

4.48

1.08-23.57

7.32**

1.57-54.05

0.89

0.55-1.37
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MANUSCRIPT 2
© Copyright 2019
Individual-Level Vulnerability Factors and Their Individual, Syndemic, and
Interactive Associations with Adherence in the MASH Cohort Study from 20092014

Abstract
Introduction: Adherence is a fundamental component of the HIV care continuum.
Achieving effective adherence can be problematic for many, particularly among those
exposed to multiple individual level vulnerability factors (i.e. depression, cocaine use,
marijuana use, education, and alcohol abuse). Individual-level vulnerability factors
rooted in social and behavioral contexts are hypothesized to additively or multiplicatively
interact to increase the risk of poorer HIV outcomes. We have examined the frequency
distribution of individual-level vulnerability factors and the associations of individuallevel vulnerability factors in a syndemic framework on medication adherence measured
in the short-term (100% adherence in the last 4-days), and long term (100% adherence in
the last 3 months or more). Methodology: The sample was derived from the Miami Adult
Studies on HIV/AIDS (MASH) cohort study from 2009-2014. The frequency distribution
of variables was first assessed. Variables were entered into a multiple logistic regression
with adherence as the outcome to determine which individual-level factors were
significantly associated with adherence. Subsequently, backward regression was used to
determine two-way interactions associated with adherence. A multivariable logistic
regression model was used to test which number of factors were associated with
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adherence. Results: Among persons assessed for short term and long term adherence,
persons between the ages of 35–44 (80.49% and 65.00%, respectively), White-Hispanic
persons (78.26% and 76.17%, respectively), those without alcohol use disorder (77.90%
and 67.50%, respectively), and males (76.40% and 67.07%, respectively) had the highest
percentages of adherence. Results showed that cocaine use was significantly and
negatively associated with short term adherence when compared to persons who tested
negative for cocaine use (OR=0.23, 95%CI: 0.05–0.86, p=0.05). Education had a
significant negative association with long term adherence (OR=0.73, 95%CI: 0.57–0.91,
p=0.01). Conclusion: This study reports findings that cocaine use was negatively
associated with short-term adherence, and education was negatively associated with longterm adherence. We determined that White-Hispanic persons, those who did not abuse
alcohol, and males had the highest percentages of adherence which provides some insight
that may assist in targeted interventions. While certain individual-level vulnerability
factors were associated with adherence, an additive or interactive effect was not seen.
More research is needed to examine the role of interactions and syndemics on adherence.

Introduction
Achieving viral suppression is the primary goal of antiretroviral therapies (ART).
There are multiple steps leading to this outcome, including diagnosis, retention, and
antiretroviral therapy adherence. Recent literature suggests that attrition commonly
occurs throughout the continuum among persons with HIV (1). Kay and colleagues have
emphasized that reducing attrition throughout the continuum requires a focus on
individual-level factors (2). According to the behavioral model for vulnerable
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populations, individual-level factors are stratified into the following categories:
traditional factors, vulnerability factors, and enabling factors (3). Traditional factors
include demographic information such as age, gender, race/ethnicity, and education.
Vulnerability factors include mental illness and substance abuse (3). Enabling factors can
impede or enhance access to HIV care and include income, insurance, housing, and social
support (3). Specific individual-level factors that have been suggested to reduce progress
to the adherence stage of the HIV care continuum include less than a high school
education, depression, cocaine use, marijuana use, and alcohol use (4-7).
Adherence is a fundamental component of the HIV care continuum. Adherence is
defined by multiple criteria, as there is no gold standard of measuring adherence in the
literature(8). Short term adherence has been defined as not skipping medications in the
last 4 days and long term adherence has been defined as not skipping medications within
the last three months (9-11). The literature and clinical findings advocate for nearly
perfect adherence to HIV antiretroviral therapies, therefore adherence in this study is
defined as “never having skipped medications” (8,12).
Although there are studies involving the association between separate individual
level vulnerability factors and adherence, the frequency of multiple individual level
vulnerability factors within a sample of prospectively followed HIV infected persons has
not been fully explored. This distribution must be understood for the purpose of
developing a more concise target group for interventions and a clearer comprehension of
the distribution of these individual-level vulnerability factors within a vulnerable
population.
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The association between multiple factors on adherence is typically assessed
independently, however, these factors do not occur separately from one another, but in
concert with one another in multiple complicated ways. Syndemic and additive
associations may explain the complex manner in which individual-level factors are
associated with adherence. Syndemic theory; first proposed by Merill Singer, involves a
group of reciprocally increasing health problems that work together in a context of
harmful social and physical conditions and increase vulnerability. The synergistic effect
of these health problems significantly increases the overall disease status of a population
(13). Syndemic theory suggests that a collection of health problems accumulates over a
person’s lifespan and can magnify the negative impact of one or more health problems
(14). Determining syndemic or additive associations involves determining the sum of
multiple characteristics on a particular outcome (13). An interactive association among
factors involves the simultaneous, non-additive influence of two or more variables on an
outcome (15). The purpose of this study is to examine the individual, interactive, and
syndemic effects of individual-level vulnerability factors on short and long term
adherence.
Assessing frequency distributions of individual-level vulnerability factors may
provide insight related to the development of a more concise target group for adherence
interventions and a clearer comprehension of the distribution of these individual-level
vulnerability factors within a vulnerable population(16). Assessing the syndemic
associations between individual-level vulnerability factors and adherence may allow
determination of whether individual-level vulnerability factors work synergistically to
impede progression to adherence among adults with HIV who have been retained in
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care(14). Interactive associations may allow researchers to determine the method in
which individual-level vulnerability factors influence the relationship between
independent variables and progression to adherence among HIV infected adults that have
been retained in care(17). Including individual level traditional factors in the assessment
of the association between individual-level vulnerability factors and adherence allows
researchers to control for demographic factors that could alter the association.
In this study, we evaluate the frequency distribution of individual-level
vulnerability factors and the individual, interactive, and syndemic associations between
individual-level vulnerability factors and adherence (both short term and long term) to
antiretroviral therapies among HIV positive adults that are retained in care.

Methods
Setting and Population
The sample was derived from the Miami Adult Studies on HIV/AIDS (MASH)
cohort study. Further details related to the methodology of the original project can be
found in a paper entitled, “Cocaine Use and Liver Disease are Associated with All-Cause
Mortality in the Miami Adult Studies in HIV (MASH) Cohort” (18). This is a secondary
analysis of a prospective cohort study involving 134 HIV positive individuals residing in
the south Florida region. Participants were a subset of the more than 800 participants
from the MASH cohort who have been followed from 2009 - 2014. All independent
variables were assessed at baseline and participants were subsequently followed for a
one-year period after baseline to determine retention status. All participants provided
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written consent to participate in the original study (MASH Cohort Study) consistent with
the Florida International University Institutional Review Board IRB: 13-0038.

Eligibility Criteria
Study participants for this analysis were eligible if (1) they were eighteen years of
age or older (2) diagnosed with HIV by a standardized testing method (3) participated in
the study from 2009-2014 (4) provided informed consent during the visit or interview (5)
retained in HIV care (6) and had complete information for both information gathered at
baseline and adherence.

Measures
The primary outcome of this study was adherence, using two time-dependent
measures. Short term adherence was defined as not having missed any doses of
medication within the last four days (8,9,12). Long term adherence was defined as those
who have not missed any medications for 3 months or more (8,10,12). Assessment of
adherence was conducted using the validated AIDS Clinical Trial Group (ACTG) survey
(8). To determine long term adherence participants were asked, “When was the last time
you missed any of your medications”? The response choices to this question were: within
the past week, 1-2 weeks ago, 2-4 weeks ago, 1-3 months ago, more than three months
ago, and never skip medications. This variable was coded as dichotomous. Persons who
answered, “within the last week, “1-2 weeks ago”, “2-4” weeks ago”, “1-3 months ago”
were considered non-adherent, those who indicated that they “never skip medications” or
“skipped more than 3 months ago” were considered to have attained long term adherence.
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Short term adherence was determined by posing the following question “During the past
4 days on how many days have you missed taking all your doses?” Persons who
answered, “1”, “2”, “3”, or “4” were coded as non-adherent, those who answered “0”
were coded as adherent. A six month time frame between baseline and adherence is
generally the time allotted for progression from initiation of the study to adherence when
using indirect methods (19). Using a 6-month time period between baseline and
adherence standardized the duration of assessment for each participant and therefore
reduced the possibility of reverse causation of poor adherence being caused by declining
health status (20).
Independent variables included sociodemographic factors such as age,
race/ethnicity, and gender. Other variables that were included were education, depressive
symptoms, and substance use. Inclusion of these independent variables in the analysis
was determined based on the behavioral model for vulnerable populations (3). Age,
race/ethnicity, and gender were determined at baseline using the validated survey:
Current Age, Gender, and Race Questionnaires (PhenX- Tier 1) (21). Education was
assessed at baseline as a categorical variable via the Current Educational Attainment
Questionnaire (PhenX Tier 1). Age was determined in the MASH survey from the selfreported year of birth and categorized in the current study as follows: “≤ 25”, “26-34”,
“35-44”, and “≥45” (22). However, age was assessed as a continuous variable in all
logistic regressions (23).
Race/ethnicity was assessed by posing the following questions to the interviewee:
What race do you consider to be? Do you consider yourself Hispanic/Latino?
Race/ethnicity was categorized in the current study as: “White (Non-Hispanic)”, “Black
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(Non-Hispanic)”, “Black (Hispanic)”, White (Hispanic), “Asian”, and “Other” (24). In
the current study, Gender was defined as a categorical variable including: “Male”,
“Female”, “Transgender”, and “Declined” (25). Education was categorized using the
following categories: “Less than high school education”, “High school graduate or
equivalent”, and “More than high school education” (26). In the logistic regressions,
years of education was assessed as a continuous variable (27).
In the MASH cohort study, the Center for Epidemiologic Studies Depression
Scale (CES-D), a validated depression questionnaire, was used to assess depressive
symptoms at baseline. Persons were asked a total of 20 questions that were scored from
0-3 (28). A score of 16 or higher indicates symptoms suggestive of clinical depression
diagnosis, while scores of 15 and below indicate that persons do not have symptoms
suggestive of clinical depression diagnosis. This variable was coded dichotomously:
“Depressed” and “Not Depressed” (28). Cocaine and marijuana use were assessed with
validated questionnaires and using the Multi-Drug 5 Panel Urine Dip Test Kit (WDOA754). This test allowed assessment of drug use within the past three days. This testing
method has been approved by the FDA (29). Cocaine and marijuana use within the past
three days were categorized dichotomously (positive or negative).
Alcohol use disorder was determined from the Alcohol Use Disorder
Identification Test (AUDIT) at baseline; this form has been validated by Saunders and
colleagues (30). This is a 10-item test summed to create a score. A score of 8 or more is
considered indicative of hazardous or harmful alcohol use. Alcohol dependence was
categorized as a dichotomous variable, either as “alcohol dependent” or “not alcohol
dependent.” (30).
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Analysis
Frequencies were determined for variables of interest (age, race/ethnicity,
education, substance use status, depression, and adherence status) and Fisher exact tests
were used to determine the association between each individual level vulnerability factor
and adherence for variables with cell counts less than 5, otherwise, chi-squared tests were
used(31). These variables were subsequently entered into a multiple logistic regression
with adherence as the outcome using two sets of models, (one for each adherence
measure) to determine which individual-level vulnerability factors are significantly
associated with adherence. After determining the individual level vulnerability factors
associated with adherence, interactions among these factors were included in the logistic
regression. To determine the syndemic or additive associations between independent
factors and adherence, a count score of the number of individual-level vulnerability
factors (from 0-5) and the frequency distribution was determined. All variables (aside
from age, race/ethnicity, and gender) were categorized dichotomously, therefore a score
of five indicates all factors were present, while a score of zero indicates none of the
factors were present (32). For the purpose of the syndemic analysis, all independent
variables that were not already dichotomous were collapsed into dichotomous variables
(32). Education was reduced to two categories (“graduated high school” and “did not
graduate high school”) (32). A multivariable logistic regression model was used run to
determine if the number of individual-level vulnerability factors is associated with
adherence (32). Odds ratios were reported at 95% confidence intervals. These odds ratios
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were used to estimate the effect of each variable and their interactions on antiretroviral
adherence. All statistical analyses were performed using R Version 3.4.3.

Results
Short Term Adherence
Table 1 summarizes demographic frequencies stratified by short term adherence.
Overall there were 134 persons in the sample for short term adherence. Approximately
75.37% (n=101) were non-adherent while 24.63% (n=33) were adherent. The majority of
the group were Non-Hispanic Black persons 72.39% (n=97). This group was primarily
composed of males (66.42%). The largest age group in the sample ( 61.65 %, n=82) were
composed of those 45 years and older. Most of the participants (63.36 %, n=83) had
received a high school education or higher. Most participants (64.18%, n=86). had an did
not have alcohol use disorder The majority tested negative for both cocaine and
marijuana (77.61%, n=104 and 83.58%, n=112, respectively), and were depressed
(72.18%, n=96). There were no significant bivariate associations.
Table 3 presents adjusted and unadjusted odds ratios for variables associated with
short term adherence. The results suggested that cocaine use was significantly and
negatively associated with short term adherence when compared to persons who tested
negative for cocaine use (OR=0.23, 95%CI: 0.05–0.86, p=0.05) when adjusting for all
other factors. There were no significant odds ratios among the unadjusted associations.
All interaction terms were non-significant at the p>0.10 threshold.
In the syndemic analysis, we determined that 41.05% (n=55) were in the twofactor category; approximately 30.59% (n=41) persons were adherent among those in the
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two-factor category and 10.45% (n=14) were non-adherent. Approximately 29.10%
(n=39) of participants had three individual level vulnerability factors. In the three-factor
category 21.64% (n=29) were adherent and 7.46% (n=10) were non adherent. The one
factor category contained 18.66% (n=25) participants (Table 5). Among those in the one
factor category, 14.18% (n=19) of persons were adherent while 4.48% (n=6) of persons
were non-adherent. The four-factor category contained 8.21% (n=11) of participants. Of
the persons with four factors, 6.72% (n=9) of persons were adherent while 1.59% (n=2)
of persons were non adherent. The five-factor category contained 0.75% (n=1) of the
participants. Three participants, 2.24%, were missing factors and excluded from analysis
(Table 5). The syndemic analysis did not yield significant results (Table 6).

Long Term Adherence
Table 2 summarizes demographic frequencies by long term adherence. Overall
there were 124 persons that had data for long term adherence. Approximately (33.06%,
n=41) of persons in this group were non-adherent, while (66.94%, n=83) were adherent.
A large majority, 77.17 %, were African American. The majority were male (66.13%,
n=82) and ≥45 years of age (60.98%, n=75). Most had a high school education or greater
(63.41%, n=78). The majority did not have alcohol use disorder 64.52% (n=80) and were
negative for both cocaine use (76.61%, n=95) and marijuana use (82.26%, n=102). There
were no significant bivariate associations between variables and long-term adherence.
Table 4 presents adjusted and unadjusted odds ratios between all variables and
≥3month adherence. The logistic regression suggests that years of education was
significantly and negatively associated with long term adherence (OR=0.73, 95%CI:
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0.57–0.91, p=0.01) when adjusted for all other factors. Demographic factors such as
race/ethnicity and male gender were not associated with adherence. Substance use and
alcohol use disorder were not associated with adherence either. There were no significant
interactions at the ≤0.10 threshold. Among the unadjusted associations between variables
and three-month adherence, education was negatively associated with reduced long-term
adherence (OR=0.76, 95%CI: 0.61–0.92, p=0.01) (Table 4).
In the syndemic analysis, 41.13% (n=51) of the participants had two individuallevel vulnerability factors (Table 5). Among those in two factor category, 28.23% (n=35)
of persons were adherent while 12.90% (n=16) of persons were non-adherent (Table 5).
Approximately 29.84% (n=37) of the participants had three individual-level vulnerability
factors. Of those in the three-factor category 16.94% (n=21) of persons were adherent
while 12.90% (n=16) were non- adherent (Table 5). The one factor category contained
17.74% (n=22) (Table 5). Among those in the one factor category, 12.90% (n=16) of
persons were adherent while 4.84% (n=6) were non-adherent. The four factors category
contained 8.87% (n=11) (Table 5). Of those in the four factors category, 6.45% (n=8) of
persons were adherent while 2.42% (n=3) of persons were non-adherent. The five factors
category contained 0.81% (n=1); all persons in this category were adherent (Table 5).
The remaining 1.61% (n=2) had missing values and were not included in the syndemic
analysis (Table 5). The bivariate analysis between the number of factors and adherence
yielded no significant results, nor did the remainder of the syndemic analyses (Table 6).
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Discussion
This study presents evidence supporting the negative association between cocaine
use and short term adherence and is consistent with the general body of literature(4).
Multiple explanations have been offered relating to this association in recent literature.
Previous literature indicates that both illicit substance dependence and HIV are associated
with neurocognitive impairment(33). These impairments may manifest as reduced
attention, processing speed, and memory(33). These HIV-related cognitive impairments
may lead to poorer adherence(33). Studies also suggest that psychostimulant use causes
less activation in various areas of the brain (i.e. prefrontal cortex, orbitofrontal cortex,
anterior cingulate, and posterior parietal region)(33). This reduced activation causes
worse performance in memory tasks and therefore reduced adherence(33). Cocaine users
with HIV may be at increased risk for neurocognitive impairment, and neurocognitive
impairment may partially explain the lower rates of medication adherence observed in
cocaine users(33). A clinical implication of this finding is to include substance
counseling along with adherence interventions among non-adherent persons with HIV
infection (Meade et al. 2011).
Notable similarities and differences in the variable frequencies were noticed when
assessing short term and long-term adherence. Among those assessed for short term
adherence, the majority were adherent, and also, we noticed the same trend among those
assessed for long term adherence. This trend is corroborated with current literature (34).
All persons in this sample are retained in care and generally, most persons who are
retained in care tend to be adherent (34). This is likely the case because persons who are
retained consistently engage in HIV-related care and therefore can be monitored and
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influenced by health professionals to engage in proper adherence (35). White-Hispanic
persons had the highest levels of adherence for both short term and long-term adherence.
Hispanic persons tend to have a percentage of adherence comparable to Non-Hispanic
white persons and a higher percentage of adherence when compared to African
Americans (36). Specifically, Hispanics of European descent tend to have higher
adherence percentages than Black persons and Hispanic persons with origins in Central
and South America(37). The reason the White Hispanic group had a higher percentage of
adherence than all other groups in this study may be due to bilingualism which has been
evidenced to improve HIV care outcomes (38). Given the large Hispanic population in
Miami, bilingualism is prevalent in most healthcare institutions. Another reason White
Hispanic persons may have higher percentages may be a higher degree of acculturation.
Studies have indicated that acculturation may strongly affect health related behavior
among minority groups in an Anglo majority host culture (i.e. United States) and
specifically compliance with treatment among Hispanic persons(39). This suggests that
the White-Hispanics may have a higher degree of acculturation than other minorities in
the study, and therefore this could be the reason for a higher adherence percentage among
this group compared to all others. Most research assesses Hispanic persons as a general
group, therefore more research may be necessary to determine the reason these trends are
not found in the Black Hispanic group.
Persons between the ages of 35-44 had a higher short-term adherence percentage
than all other age groups, however persons 26-34 had the highest long-term adherence
percentage. These persons had an adherence percentage of 100%, however, this group
consisted of only 8 participants. A larger group of persons from this age group may be
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necessary to develop inferences related to age and long-term adherence. Among groups
with a larger number of participants and an actual non-adherent segment, persons
between the ages of 35-44 had the highest percentage of long-term adherence. Persons
with high levels of adherence are generally older therefore, it is consistent with the
literature that the youngest group (≤25) would not have the highest percentage of
adherence (40). A number of explanations have been presented to explain this trend. One
explanation for the increased percentage of adherence among an older group is that older
HIV patients are already familiar with medication usage for chronic diseases and have
increased awareness that treatment of HIV requires a high level of medication
adherence(41). Another explanation presented by the literature is that older HIV patients
have had friends or who passed away from infections associated with HIV/AIDS,
principally during the height of the HIV epidemic when treatment options were limited,
and this has shaped their desire to maintain control of this disease(41). The oldest group
(≥45), did not have the highest percentage of short term or long-term adherence. While
this is not consistent with the majority of literature, some literature does corroborate this
finding as older patients with evidenced cognitive decline are likely to have poorer
adherence (1,42).
Males had a higher percentage of both short term and long-term adherence than
did females. This finding is corroborated by the current literature (43). The reasoning
offered for this trend is that females report more avoidance coping mechanisms in
managing HIV related stress, including the stress that results from publicly taking
antiretroviral therapies in public. This may explain more frequent adherence among
males than females(44). Another possibility could be the practical barriers to adherence
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frequently experienced by women living with HIV such as taking care of a household and
children(43)
In both short term and long-term adherence persons who did not have alcohol use
disorder had the highest percentages of adherence. The trend of increased percentages of
adherence among those who did not have alcohol use disorder when compared to those
do not is consistent with current literature (45). While these percentages are not
statistically significant, they may be clinically significant in helping researchers develop
interventions to improve adherence among persons with HIV. Specifically, persons ≤25,
females, and persons who may have symptoms suggestive of alcohol use disorder may
need additional counseling and monitoring related to adherence.
Among those assessed for long term adherence, we found that increased education
was negatively and significantly associated with adherence. This finding is corroborated
in the literature, indicating a statistically significant negative relationship between
adherence and years of education completed; however, most literature which assesses the
relationship between education and long term adherence generally find that a reduced
level of education is associated negatively with long term adherence (46,47). Studies
have suggested a potential reason for the negative association between years of education
completed and adherence is fear of HIV stigma among more educated persons, resulting
in avoidance of HIV clinics and therefore less consistent use of medication(48). Upon
assessing the distribution of education relative to other variables, we determined that the
majority of persons, 55.55% (n=5), with more than two years of college had alcohol use
disorder in this sample. Alcohol abuse has been associated with reduced adherence
among persons with HIV(6). We removed this educational class (persons with >2 years
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of college) and ran a logistic regression again. Education was no longer significantly and
negatively associated with adherence. Please see the supplemental table below (Table 7).
These equivocal findings suggest that a more detailed study of the effect of education on
adherence is warranted.
There were no significant findings in the syndemic analysis, nevertheless, the
distribution of factors is interesting. The majority of persons who had attained short term
and long-term adherence were concentrated in the two and three factor categories. This is
significant because it suggests that most persons adherent antiretroviral therapy have two
to three vulnerability factors that could affect their health outcomes. Assessing the
number of vulnerability factors an HIV infected patient has could inform clinical
practices and improve care for those with HIV. Determining a threshold or index that
sufficiently predicts success along the HIV care continuum, also may be useful.
A major strength of this study was a diverse group of HIV infected persons from
the Miami-Dade area including Hispanics and Blacks; two groups most affected by HIV
in the United States. Another strength of this study was the multiple variables available in
the data allowing assessment of how factors independently affect adherence while
controlling for others.
A major limitation was a small sample size for these types of analyses,
contributing to the wide confidence intervals around some of the point estimates. The
small sample size limited the statistical power of the syndemic analysis, which may have
contributed to the null findings. The four and five factor groups for the syndemic
comparisons in both the short term and long-term analysis contained 11 and 1 persons,
respectively. In an attempt to assess whether the insignificant findings were an artifact of
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a small group size the “four” and “five” factor categories were combined in a sensitivity
analysis. There were no significant findings; which suggests that the accumulation of
individual level vulnerability factors does not additively impact antiretroviral adherence
among this group. The syndemic theory suggests that a collection of health-related
factors accrues over a person’s lifespan and can increase the negative impact of one or
more health problems (14). More research is necessary to determine the specific factors
that could accumulate and possibly reduce both short term and long-term adherence.
Further research is also needed to assess the manner in which the theory of syndemics
applies to adherence to HIV care in a population suffering from disparities.

Conclusion
This study reports findings that cocaine is negatively associated with adherence
within the last four days and education was negatively associated with adherence within
the last three months. This study also indicates that the distribution of individual-level
factors is similar among those with short term and long-term adherence. The majority of
these retained subjects were adherent. Adherent persons tended to be older, WhiteHispanic, did not have alcohol use disorder, and male. While the findings related to
frequency distribution among variables may not be statistically significant, they may be
significant in helping researchers develop interventions to improve adherence among
persons with HIV. Syndemic and interactive outcomes were not significant and therefore
did not provide further insight into the effects of multiple risk factors. Future research is
necessary to further assess the relationship between varying levels of substance use,
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education and adherence among persons with HIV. Future research is also necessary to
assess the syndemic theory’s relation to adherence in HIV care.
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Tables
Table 1: Frequency of Demographic Characteristics and Drug Use Among Retained
Persons in the MASH Cohort in Miami-Dade County from 2009-2014
Not Adherent
(n=33, 24.63%)
last 4 days
Race/Ethnicity
White
White (Hispanic)
Black
Black (Hispanic)
Other
Missing
Gender
Male
Female
Missing
Age
≤25
26-34
35-44
≥45
Missing
Education
<HS
HS
>HS
Missing
AUDIT score
<8
≥8
Missing
Cocaine Use
Positive
Negative
Missing
Marijuana Use
Positive

Adherent
(n=101,
75.37%)
last 4 days

Missing

Fisher Exact
Test pvalue/ChiSquared
0.31

2 (40.00%)
5 (21.74%)
22 (22.68%)
1 (50.00%)
2 (33.33%)

3 (60.00%)
18 (78.26%)
75 (77.32%)
1 (50.00%)
4 (66.67%)
0 (0.00%)
0.86*

21 (23.60%)
12 (26.67%)

68 (76.40%)
33 (73.33%)
0 (0.00%)
0.44

1 (50.00%)
1 (12.50%)
8 (19.51%)
23 (28.05%)

1 (50.00%)
7 (87.50%)
33 (80.49%)
59 (71.95%)
1 (0.10%)
0.83*

10 (20.83%)
15 (25.86%)
6 (24.00%)

38 (79.17%)
43 (74.14%)
19 (76.00%)
3 (2.24%)
0.48*

19 (22.10%)
14 (29.17%)

67 (77.90%)
34 (70.83%)
0 (0.00%)
0.15

4 (13.79%)
29 (27.88%)

25 (86.21%)
75 (72.12%)
1 (0.10%)
0.59

4 (19.05%)

17 (80.95%)

75

Negative
29 (25.89%)
83 (74.11%)
Missing
1 (0.10%)
Depression
Positive (CES-D
1(1.04%)
95 (98.96%)
score ≥16)
Negative (CES-D
32 (84.21%)
6 (15.79%)
score <16)
Missing
1 (0.10%)
*Indicates Chi-squared test, otherwise Fisher exact test used
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1.00

Table 2: Frequency of Demographic Characteristics and Drug Use Among
Retained Persons in the MASH Cohort in Miami-Dade County from 2009-2014
Adherent
Fisher Exact
Not Adherent
(n=83,
Test p(n=41, 33.06%)
Missing
66.94%) last 3
value/Chilast 3 months
months
Squared
Race/Ethnicity
0.48
White
2 (40.00%)
3 (60.00%)
White (Hispanic) 5 (23.81%)
16 (76.19%)
Black
29 (32.58%)
60 (67.42%)
Black (Hispanic) 2 (66.67%)
1 (33.33%)
Other
3 (75.00%)
1 (25.00%)
Missing
0(0.00%)
Gender
1.00*
Male
27 (32.93%)
55 (67.07%)
Female
14 (33.33%
28 (66.67%)
Missing
0(0.00%)
Age
0.21
≤25
0 (0.00%)
1 (100.00%)
26-34
0 (0.00%)
7 (100.00%)
35-44
14 (35.00%)
26 (65.00%)
≥45
27 (36.00%)
48 (64.00%)
Missing
1 (0.01%)
Education
0.13*
<HS
11 (24.44%)
34 (75.56%)
HS
18 (33.96%)
35 (66.04%)
>HS
12 (48.00%)
13 (52.00%)
Missing
1 (0.01%)
AUDIT score
1.00*
<8
26 (32.50%)
54 (67.50%)
≥8
15 (34.09%)
29 (65.91%)
Missing
0 (0.00%)
Cocaine Use
0.40*
Positive
7 (25.00%)
21 (75.00%)
Negative
34 (35.79%)
61 (63.21)
Missing
1 (0.01%)
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Marijuana Use
Positive
Negative
Missing
Depression
Positive (CES-D
score ≥16)

0.44*
9 (42.86%)
32 (31.37%)

12 (57.14%)
70 (68.63%)
1 (0.01%)
0.22

37 (31.62%)

Negative (CES-D
4 (57.14%)
score <16)

80 (68.38)
3 (42.86%)

Missing

0 (0.00%)

*Indicates Chi-squared test, otherwise Fisher exact test used
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Table 3: Adjusted Odds Ratio (AOR) and Unadjusted Odds Ratio (OR)
for 4 Day Adherence Among the MASH Cohort Retained Participants
in Miami-Dade, FL from 2009-2012
(AOR)

(OR)

Variable
Depression

AOR

95%CI

CES-D Score ≥16
CES-D Score <15
Marijuana Use

1.40

0.19–
28.91

Marijuana Use (+)
Marijuana Use (-)
AUDIT Score
AUDIT Score≥8
AUDIT Score<8
Cocaine Use
Cocaine (+)
Cocaine (-)
Education (yrs)
Education
Age (yrs)
Age
Race/Ethnicity
White (Hispanic)
Black (Non-Hispanic)
Black (Hispanic)
Other
White (Non-Hispanic)
Gender
Female

Ref.
0.18–
2.57

0.74
Ref.

0.58–
3.85

1.50
Ref.

0.05–
0.86

0.24**
Ref.

OR

95%CI

2.02
Ref.

0.33–38.93

0.67
Ref.

0.18–2.00

1.45
Ref.

0.64–3.24

0.41
Ref.

0.11–1.18

1.02

0.86–
1.23

1.01

0.85–1.20

0.98

0.92–
1.04

0.99

0.95–1.05

0.41

0.05–3.81

0.44

0.07–3.50

3.00

0.16–97.62
0.05–9.59

Ref.

0.75
Ref.

1.00

1.00

0.03–
3.12
0.05–
3.33
0.16–
128.56
0.05–
12.87

3.30
0.37
3.48
0.79
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Male
Female
**p-value≤0.05
*p≤0.10
No significant interactions for
Adherence at 4 days

0.30–
1.93

0.76
Ref.

80

0.85
Ref.

0.38–1.97

Table 4: Adjusted Odds Ratio (AOR) Unadjusted Odds Ratio (OR)for 3
Month Adherence Among the MASH Cohort Retained Participants
in Miami-Dade, FL from 2009-2012
(AOR)

(OR)

Variable
Depression

AOR

CES-D Score ≥16
CES-D Score <15
Marijuana Use
Marijuana Use (+)
Marijuana Use (-)
AUDIT Score
AUDIT Score≥8
AUDIT Score<8
Cocaine Use
Cocaine (+)
Cocaine (-)
Education (yrs)
Education
Age (yrs)
Age
Race/Ethnicity

4.31*
Ref.

95%CI
0.81–
25.48

OR

95%CI

2.88
Ref.

0.61–15.26

0.72
Ref.

0.23–2.23

0.61
Ref.

0.23–1.63

0.98
Ref.

0.37–2.60

0.93
Ref.

0.43–2.06

2.15
Ref.

0.72–7.26

1.67
Ref.

0.67–4.61

0.73**

0.57–0.91

0.76**

0.61–0.92

1.00

0.94–1.07

0.98

0.93–1.04

2.13

0.23–16.94

1.37

0.17–8.76

0.33

0.01–6.15

0.67
Ref.

0.05–7.47

White (Hispanic)

4.75

Black (Non-Hispanic)

2.03

Black (Hispanic)

0.50

Other
White (Non-Hispanic)
Gender
Female
Male
Female

1.50
Ref.

0.39–
60.49
0.20–
18.85
0.01–
11.78
0.09–
25.13

1.00
1.21
Ref.

0.48–3.03

**p-value≤0.05
*p≤0.10
No significant interactions for
Adherence at 4 days
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1.00
1.02
Ref.

0.46–2.28

Table 5: Frequency Distribution of Factors in the
MASH Cohort in Miami-Dade County from 2009-2012

Three

(4-Day Adherence)
Frequency Frequenc
(%) of
y (%) of
category
category
among
among
adherent
nonadherent
19
(14.18%)
6(4.48%)
41
14
(30.59%)
(10.45%)
29
10
(21.64%)
(7.46%)

Four

9 (6.72%)

2 (1.59%)

11 (8.21%)

Four

(3 Month Adherence)
Frequenc Frequency Total
y (%) of
(%) of
Frequenc
category
category
y (%)
among
among
overall
adherent
nonadherent
16
22
6 (4.84%) (12.90%)
(17.74%)
16
35
51
(12.90%)
(28.23%)
(41.13%)
16
21
37
(12.90%)
(16.94%)
(29.84%)
11
3 (2.42%) 8 (6.45%)
(8.87%)

Five

1 (0.75%)

0 (0.00%)

1 (0.75%)

Five

0 (0.00%)

1 (0.81%)

1 (0.81%)

Missing

1 (0.75%)

2 (1.49%)

3 (2.24%)

Missing

0 (0.00%)

2 (1.61%)

2 (1.61%)

Numbe
r of
Factors

One
Two

Total
Frequency
(%)
overall

25
(18.66%)
55
(41.04%)
39
(29.10%)

Numbe
r of
Factors

One
Two
Three
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Table 6: Adjusted Odds Ratio for the Syndemic Association with Adherence in
the MASH Cohort in Miami-Dade County from 2009-2014

Variable
Number of Factors
Number of Factors
Age
Age
Race/Ethnicity
White Non-Hispanic
WH
Black
BH
Other
Gender
Female Gender
Male Gender

Model 1 (4-Day
Adherence)
AOR
95%CI

Model 2 (3-Month
Adherence)
AOR
95%CI

0.86

0.52–1.41

0.87

0.55–1.39

0.99

0.94–1.04

0.98

0.92–1.03

1.00
0.37
0.39
2.83
0.73

0.04–3.49
0.06–3.20
0.15–93.49
0.05–9.39

1.00
2.03
1.27
0.32
0.64

0.21–16.66
0.15–8.37
0.01–5.93
0.05–7.24

0.35–2.03

1.00
1.04

0.45–2.38

1.00
0.83
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Supplemental Table
Table 7: Adjusted Odds Ratio (AOR) Unadjusted Odds
Ratio (OR)for 3 Month Adherence
Among the MASH Cohort Retained Participants
in Miami-Dade, FL from 2009-2012
Variable
Depression
CES-D Score ≥16
CES-D Score <15
Marijuana Use
Marijuana Use (+)
Marijuana Use (-)
AUDIT Score
AUDIT Score≥8
AUDIT Score<8
Cocaine Use
Cocaine (-)
Cocaine(+)
Education (yrs)
Education
Age (yrs)
Age
Race/Ethnicity
White (Hispanic)
Black (Non-Hispanic)
Black (Hispanic)
Other
White (Non-Hispanic)
Gender
Male
Female
**p-value≤0.05
*p≤0.10

84

AOR

95%CI

4.82*
Ref.

0.84–30.51

0.40
Ref.

0.11–1.41

1.12
Ref.

0.40–3.34

Ref.
2.72

0.86–10.15

0.76

0.56–0.99

0.78

0.56–1.04

7.68
2.46
0.58
0.90
Ref.

0.53–129.98
0.23–27.95
0.01–16.12
0.04–17.50

1.99
Ref.

0.37–2.60

MANUSCRIPT 3

© Copyright 2019
The Individual and Interactive Effects of Substance Use, Depression,
Education, Race/Ethnicity, and Gender on Viral Suppression Among PLWH
Retained in Care

Abstract
Objective: To determine significant individual-level (traditional and vulnerability) factors
and interactions associated with viral suppression. Background: Achieving viral
suppression is the principal goal of antiretroviral therapies (ART). This is the ultimate
component of the HIV care continuum; it follows the diagnosis, retention, and adherence
stages. Traditional individual-level traditional factors that have been suggested to reduce
progression to viral suppression are age, race/ethnicity, and gender. Specific individuallevel vulnerability factors that have been demonstrated to reduce progress to the “viral
suppression” stage of the HIV care continuum include depression, cocaine use, marijuana
use, alcohol use, and tobacco use. These individual-level-factors may individually and
interactively reduce progression to viral suppression. Methods: The sample (n= 51) was
derived from the Miami Adult Studies on HIV/AIDS (MASH) cohort study from 2009–
2014. This is a prospective cohort composed of comprehensively characterized active
drug users, with and without HIV infection. Individual-level traditional and vulnerability
factors were entered into a multiple logistic regression with viral suppression as the
outcome to determine which individual-level factors were significantly associated with
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retention. Subsequently, backward regression, adjusting for all main effects was
conducted, to determine two-way interactions associated with viral suppression. Results:
The sample consisted primarily of 78.43% Non-White persons, males (64.71%), and
persons ≥35 years of age (88.24%). Among the adjusted odds ratios Non-White
race/ethnicity was marginally and negatively associated with viral suppression (OR=0.23,
95%CI: 0.03–1.10, p=0.08). Among the unadjusted odds ratios Non-White race/ethnicity
(OR=0.28, 95%CI: 0.05–1.12, p=0.09), education (OR=0.75, 0.52–1.03, p=0.10), and
male gender (OR=0.33, 95%CI: 0.09–1.05. p=0.07) were marginally and negatively
associated with viral suppression. No interactions were significant. Conclusion: This
study reports findings that indicate male gender, Non-White race/ethnicity, and education
are marginally and negatively associated with viral suppression. Future research is
necessary to explore the individual and interactive associations between individual-level
factors and viral suppression.

Introduction
Achieving HIV viral suppression is the principal goal of antiretroviral therapies
(ART)(1). This is the final component of the HIV care continuum; the diagnosis,
retention, and adherence stages precede it(1). Recent literature indicates that among all
persons who are diagnosed with HIV in the United States, approximately 48% are virally
suppressed (2). Kay and colleagues have noted that decreasing attrition throughout the
continuum necessitates a focus on individual-level factors (3). According to the
behavioral model for vulnerable populations, individual-level factors are divided into the
following categories: traditional factors, vulnerability factors, and enabling factors (4).
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Traditional factors include demographic information such as age, gender, race/ethnicity,
and education. Vulnerability factors include factors such as mental illness and substance
abuse (4). Individual-level traditional factors that have been determined to reduce
progress to viral suppression are race/ethnicity, gender, and age (5-8). Specific
individual-level vulnerability factors that have been demonstrated to reduce progress to
the “viral suppression” stage of the HIV care continuum include depression, cocaine use,
marijuana use, alcohol use, and cigarette use (9-14). Although substance use generally
includes illicit substances and alcohol use in the scope of viral suppression, we included
tobacco use as it has been evidenced to reduce T-cell viability and therefore indirectly
increase the viral load (4,14)
Viral suppression is a vital component of the HIV care continuum. While there
are multiple definitions of viral suppression, we defined viral suppression as an HIV viral
load of ≤50 copies per mL during the 12 month follow-up period (15-18). The association
between multiple factors on viral suppression is generally assessed individually while
adjusting for others, however, these factors do not occur in isolation from one another.
They occur in concert with one another in multiple ways. Interactive associations among
factors involve the simultaneous, non-additive influence of two or more variables on an
outcome (19). The purpose of this brief is to examine the individual and interactive
effects of individual-level traditional and vulnerability factors on viral suppression. We
hypothesize that multiple individual level traditional and vulnerability factors will be
associated with viral suppression. We also hypothesize that there will be an interactive
effect among these factors.
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Understanding individual-level associations assists researchers in understanding
the deleterious effects of specific individual-level factors on viral suppression among
persons living with HIV(PLWH) Understanding interactive associations allows
researchers to determine putative mechanisms in which individual-level (traditional and
vulnerability) factors influence the relationship between independent variables and
progression to viral suppression among PLWH that have been retained in care.

Methods
Setting and Population
The sample was derived from the Miami Adult Studies on HIV/AIDS (MASH) cohort
study. Further details related to the methodology of the original project can be found in a
paper entitled, “Cocaine Use and Liver Disease are Associated with All-Cause Mortality
in the Miami Adult Studies in HIV (MASH) Cohort” (20). This is a secondary analysis of
a prospective cohort study involving 51 HIV positive individuals residing in the south
Florida region. Participants were a subset of the more than 800 participants from the
MASH cohort who have been followed from 2009 - 2014. All independent variables were
assessed at baseline and participants were subsequently followed for a one-year period
after baseline to determine retention status. All participants provided written consent to
participate in the original study (MASH Cohort Study) consistent with the Florida
International University Institutional Review Board IRB: 13-0038.
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Eligibility Criteria
Participants were eligible for this analysis if they were (1) eighteen years of age or
older, (2) diagnosed with HIV by a standardized testing method, (3) participated in the
study from 2009-2014, (4) provided informed consent, (5) were retained in care for a
period ≥3 months during the calendar year in which we assessed viral suppression (6) had
complete information gathered at baseline and (7) had complete viral suppression
information at the 12 month follow-up period.

Measures
The primary outcome of this study was viral suppression at 12 month follow up.
Viral suppression was defined as an HIV viral load of ≤50copies per mL in the calendar
year among HIV positive persons on antiretroviral therapies (ART) (16). Those who met
this criterion were codified as virally suppressed, and those who did not were codified as
not virally suppressed. The time period between baseline and viral suppression was
twelve months, as that is the time interval that is generally allotted for progression to viral
suppression among persons with HIV (17,18). HIV viral load was determined via
laboratory reports and assessed using polymerase chain reaction (RealTime HIV-1 PCR;
Abbott Molecular, Des Plaines, IL) after appropriate medical release forms were signed
by the parties (21).
Independent variables that were analyzed included sociodemographic factors such
as age, race/ethnicity, and gender. Other variables that were included are education,
depressive symptoms, and substance use. Inclusion of these independent variables in the
analysis was determined according to the behavioral model for vulnerable populations
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(4). Age, race/ethnicity, and gender were obtained at baseline using a validated survey:
Current Age, Gender, and Race Questionnaires (PhenX- Tier 1). Education was assessed
at baseline as a categorical variable via the Current Educational Attainment
Questionnaire (PhenX Tier 1) (22).
The Center for Epidemiologic Studies Depression Scale (CES-D), a validated
depression scale, was used to assess depression at baseline. Persons were asked a total of
20 questions that were scored from 0-3 (23). A score of 16 or higher indicated symptoms
suggestive of clinical depression diagnosis, while scores of 15 and below indicated that
persons do not have symptoms suggestive of a clinical depression diagnosis. This
variable was coded dichotomously: “Depressed” and “Not Depressed” (23).
Cocaine use and marijuana use were assessed using the Multi-Drug 5 Panel Urine
Dip Test Kit (WDOA-754). This test allowed researchers to assess drug use in the past
three days. This testing method has been approved by the FDA (24). Cocaine and
marijuana use within the past three days were both categorized dichotomously (“positive”
or “negative”). Alcohol use disorder was determined from the Alcohol Use Disorder
Identification Test (AUDIT) at baseline; this form was validated by Saunders and
colleagues (25). This is a 10-item instrument in which each question is worth one point.
A score of 8 or more was considered indicative of hazardous or harmful alcohol use.
Alcohol dependence was categorized as a dichotomous variable, either alcohol dependent
or not alcohol dependent (25).
Tobacco use was determined by a detailed questionnaire of drug, alcohol, and
tobacco use in the past six months. The questionnaire queried the type of alcohol or drug
of abuse including beer, wine, liquor, marijuana, cocaine, crack, amphetamines, and
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tobacco, as well as frequency, quantity, and route of administration. Frequency of use
was graded on a numerical scale of 0 = never, 1 = once in the last 30 days, 2 =
once/week; 3 = 3-4 times/week, 4 = daily, and 5 = more than daily (26).

Analysis
First, frequencies were obtained for the variables age, race/ethnicity, education,
substance use status, depression, and tobacco use status, by viral suppression status. Each
variable’s association was tested with either a chi-squared test or a Fisher exact test if the
variable had a cell value≤5(27). These variables were subsequently entered into a robust
multiple logistic regression with viral suppression as the outcome to determine which
individual-level factors were significantly associated with viral suppression. We used
robust regression due to the small sample size and the effect outliers could potentially
have on the regression(28). Subsequently, backward regression, adjusting for all main
effects was conducted, to determine which two-way interactions were associated with
retention. All interactions with p≤0.10 were included in the final model (29). Odds ratios
were reported at 95% confidence intervals. These odds ratios were used to estimate the
effect of each variable and their interactions on viral suppression. All statistical analyses
were performed using R Version 3.4.3

Results
Table 1 summarizes viral suppression frequencies of 51 participants in the sample
as well as their demographic characteristics. Overall, 50.98% (n=26) were not virally
suppressed. The majority of participants were Non-White (Black, Black-Hispanic, and
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Other) while the remainder, 21.47% (n=11) were White (Non-Hispanic White and White
Hispanic). Approximately 64.71% (n=33) participants were male. The majority of
persons were over the age of 35 (88.24 %, n=45) while some were under the age of 35
(11.76%, n=6). Most of the participants had a high school education or some postsecondary education (68.63%, n=35).
Cocaine and marijuana use in the last three days was minimal (17.65%, n=9 and
(19.61%, n=10, respectively). The majority of persons did not have alcohol use disorder
(66.67%, n=34) and used tobacco at least 3-4 times per week (56.86%, n=29). The
majority of persons had depressive symptoms consistent with a diagnosis of depression
(94.12%, n=48). Model 1 (Table 1), which illustrates a logistic regression with all
individual-level factors excluding interactions, shows there were no significant
associations between any individual-level factors and viral suppression among this group.
When assessing interactions associated with viral suppression, there were no statistically
significant interactions. While there were no statistically significant factors, there were
some marginally significant factors at the p≤0.10 threshold (29). Among the adjusted
odds ratios Non-White race/ethnicity was negatively associated with viral suppression
(OR=0.23, 95%CI: 0.03–1.10, p=0.08) (Model 1, Table 1). Among the unadjusted odds
ratios Non-White race/ethnicity (OR=0.28, 95%CI: 0.05–1.12, p=0.09), education
(OR=0.75, 0.52–1.03, p=0.10), and male gender (OR=0.33, 95%CI: 0.09–1.05. p=0.07)
were negatively and marginally associated with viral suppression (Model 2, Table 1).
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Discussion
Although there were no significant individual-level factors or interactions, there were
marginally significant factors associated with viral suppression. Non-White race/ethnicity
had a negative and marginally significant association with viral suppression. This finding
is corroborated by other studies (5). Recent research has suggested that this disparity may
be due to reduced adherence as a result of medical mistrust, and differences in prescribed
regimen or setting (30). Another reason for this finding may be stigma. Previous research
suggests that stigma may also play a role in reducing viral load among African
Americans and Latinos causing many of them not to seek care and therefore maintain a
higher viral load(31) More research is necessary to better understand the racial disparities
as they relate to viral suppression among persons with HIV (30). Male gender was also
negatively associated with viral suppression. Although this is not typical, some literature
does corroborate this finding (6,32). Scarce research exists regarding reasoning for the
gender differences in viral suppression and most literature attributes these differences to
other factors such as gender-specific differences in structural support and homelessness
(6,32). Education was negatively associated with viral suppression. Similar, but nonsignificant trends have been reported in previous literature (33,34). Studies have
suggested a potential reason for the negative association between years of education
completed and adherence is fear of HIV stigma among more educated persons, resulting
in avoidance of HIV clinics and therefore less consistent use of medication(35). Less
consistent use of medication would result in reduced viral suppression(36). This
association may be due to small cell sizes in this sample. Categories of six, seven, and
eight years of education only had one person per category. These small cell sizes can alter
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an association(37). After removing these educational categories, education was no longer
marginally associated with viral suppression. More research is necessary to further
explain this trend.
In the preliminary analysis, researchers found the interaction between alcohol use
disorder and education was significantly associated with viral suppression, suggesting
that the effect of alcohol use disorder on viral suppression varies according to education
level (or equivalently the effect of education on viral suppression varies by alcohol use
disorder). An implication of this finding would be to develop more exploratory studies to
determine the rationale related to the interaction’s positive association with viral
suppression. Education may be a significant predictor of later viral suppression because
it is capturing the effect of adulthood resource disparities, which could have long-lasting
health consequences (30). We also conducted a stratified analysis and recognized a
negative association between alcohol use disorder and viral suppression among those
with less than a high school education and recognized a slight positive association
between alcohol use disorder and viral suppression among those who had a high school
education or more. This suggests that alcohol use disorder is especially problematic for
persons with HIV and reduced education. Neither association was significant. This
interaction was removed due to collinearity with the alcohol use disorder variable as it
destabilized the model and it would have been inappropriate to include in the final
model(38).
A strength of this study was a diverse group of persons with HIV from the MiamiDade area including Hispanics and Blacks; two groups most affected by HIV in the
United States, as well as the inclusion of participants with multiple individual-level
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factors profiles. Another strength of this study was the multiple variables available in the
data, allowing assessment of how individual-level factors independently affect viral
suppression while controlling for others. An additional strength of this study was the
valid measures of vulnerability factors (i.e. substance use confirmed with urine samples).
Despite the strengths of this study, there were limitations. A major limitation was
the small sample size. This inhibited our ability to conduct interactive analyses, which in
turn limited our understanding of the association between individual-level factors and
viral suppression, however, we needed to adhere to the inclusion and exclusion criteria of
persons having been retained in care and having complete viral suppression data.

Conclusion
This study reports findings which indicate that male gender, Non-White
race/ethnicity, and education are marginally and negatively associated with viral
suppression. During the original analysis, researchers found a negative association
between alcohol use disorder*education interaction and viral suppression. We also
determined that alcohol use disorder is negatively associated with viral suppression
among those with less than a high school education. To our knowledge, this is the first
manuscript to assess viral suppression within the scope of the behavioral model for
vulnerable populations. These findings may inform the development of future viral
suppression interventions. Future research is necessary to explore the individual and
interactive associations between individual-level factors and viral suppression.

95

References

(1) Gardner EM, Maravi ME, Rietmeijer C, Davidson AJ, Burman WJ. The Association
of Adherence to Antiretroviral Therapy with Healthcare Utilization and Costs for
Medical Care. Appl Health Econ Health Policy 2008;6(2-3):145-155.
(2) Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and Ethnic Disparities in
Sustained Viral Suppression and Transmission Risk Potential Among Persons Receiving
HIV Care — United States, 2014. MMWR. Morbidity and mortality weekly report 2018
Feb 2,;67(4):113-118.
(3) Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum:
updates, goals, and recommendations for the future. AIDS research and therapy
2016;13(1):35.
(4) Katerina A. Christopoulos, Moupali Das, Grant N. Colfax. Linkage and Retention in
HIV Care among Men Who Have Sex with Men in the United States. Clinical Infectious
Diseases 2011 Jan 15,;52(suppl_2):S21-S222.
(5) H Irene Hall, Tian Tang, Andrew O Westfall, Michael J Mugavero. HIV Care Visits
and Time to Viral Suppression, 19 U.S. Jurisdictions, and Implications for Treatment,
Prevention and the National HIV/AIDS Strategy. PLoS One 2013 Dec 1,;8(12):e84318.
(6) Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of
Human Immunodeficiency Virus Treatment During Incarceration: Viral Suppression at
the Prison Gate. JAMA Internal Medicine 2014 May 1,;174(5):721-729.
(7) Torian LV, Xia Q, Wiewel EW. Retention in Care and Viral Suppression Among
Persons Living With HIV/AIDS in New York City, 2006–2010. American journal of
public health 2014 Sep;104(9):e2-e29.
(8) Cook RL, Zhou Z, Kelso-Chichetto NE, Janelle J, Morano JP, Somboonwit C, et al.
Alcohol consumption patterns and HIV viral suppression among persons receiving HIV
care in Florida: an observational study. Addiction science & clinical practice 2017 Sep
27,;12(1):22.
(9) Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, et al.
Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of
anti-retroviral therapy utilization. J Acquir Immune Defic Syndr 2011;56(2):146.
(10) Kerr T, Marshall BD, Milloy M, Zhang R, Guillemi S, Montaner JS, et al. Patterns
of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term
cohort of injection drug users. Drug Alcohol Depend 2012;124(1):108-112.

96

(11) Sinha S, McCaul ME, Hutton HE, Monroe AK, Alvanzo A, Lesko C, et al.
Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV
clinic. Journal of Substance Abuse Treatment 2017 Nov;82:102-106.
(12) Wu ES, Metzger DS, Lynch KG, Douglas SD. Association between alcohol use and
HIV viral load. J Acquir Immune Defic Syndr 2011;56(5):e129.
(13) Naveed Gulzar, Karen Copeland. CD8+ T-Cells: Function and Response to HIV
Infection. Current HIV Research 2004 Jan;2(1):23-37.
(14) Glader P, Möller S, Lilja J, Wieslander E, Löfdahl C, von Wachenfeldt K. Cigarette
smoke extract modulates respiratory defence mechanisms through effects on T-cells and
airway epithelial cells. Respiratory Medicine 2006;100(5):818-827.
(15) Michael J Mugavero, K Rivet Amico, Andrew O Westfall, Heidi M Crane, Anne
Zinski, James H Willig, et al. Early Retention in HIV Care and Viral Load Suppression:
Implications for a Test and Treat Approach to HIV Prevention. Journal of Acquired
Immune Deficiency Syndromes 2012 Jan 1,;59(1):86.
(16) Lourenço, Lillian|Hull, Mark|Nosyk, Bohdan|Montaner, Julio S G|Lima, Viviane D.
The need for standardisation of the HIV continuum of care. Lancet HIV, The
2015;2(6):e22-e226.
(17) Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S. Disparities in Engagement in
Care and Viral Suppression Among Persons With HIV. JAIDS Journal of Acquired
Immune Deficiency Syndromes 2013 May 1,;63(1):112-119.
(18) Ryscavage P, Macharia T, Patel D, Palmeiro R, Tepper V. Linkage to and retention
in care following healthcare transition from pediatric to adult HIV care. AIDS Care 2016
May 3,;28(5):561-565.
(19) Upton G, Cook I. A dictionary of statistics 3e. : Oxford university press; 2014.
(20) Campa A, Martinez SS, Sherman KE, Greer JP, Li Y, Garcia S, et al. Cocaine Use
and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in
HIV (MASH) Cohort. Journal of drug abuse 2016;2(4).
(21) Ramamoorthy V, Campa A, Rubens M, Martinez SS, Fleetwood C, Stewart T, et al.
Caffeine Intake and Its Association with Body Composition Measures and Macronutrient
Intakes in People Living with HIV in the Miami Adult Studies on HIV Cohort. Journal of
Caffeine Research 2018 Jan 11,.
(22) McCarty CA, Berg R, Rottscheit CM, Waudby CJ, Kitchner T, Brilliant M, et al.
Validation of PhenX measures in the personalized medicine research project for use in
gene/environment studies. BMC medical genomics 2014;7(1):3.

97

(23) Van Dam, Nicholas T.|Earleywine, Mitch. Validation of the Center for
Epidemiologic Studies Depression Scale—Revised (CESD-R): Pragmatic depression
assessment in the general population. Psychiatry Research 2010;186(1):128-132.
(24) Federal Drug Administration. 501k § 807.9c. 2008.
(25) SAUNDERS JB, AASLAND OG, BABOR TF, DE LA FUENTE, JUAN R,
GRANT M. Development of the Alcohol Use Disorders Identification Test (AUDIT):
WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol
Consumption‐II. Addiction 1993 Jun;88(6):791-804.
(26) Baum MK, Jayaweera DT, Duan R, Sales S, Lai S, Rafie C, et al. Quality of Life,
Symptomatology and Healthcare Utilization in HIV/HCV Co-Infected Drug Users in
Miami. Journal of Addictive Diseases 2008 Feb 27,;27(2):37-48.
(27) Winters R, Winters A, Amedee RG. Statistics: a brief overview. The Ochsner
journal 2010;10(3):213.
(28) Yu-Wen Wen, Yi-Wen Tsai, David Bin-Chia Wu, Pei-Fen Chen. The Impact of
Outliers on Net-Benefit Regression Model in Cost-Effectiveness Analysis. PLoS One
2013 Jun 1,;8(6):e65930.
(29) Wirtz AL, Zelaya CE, Peryshkina A, McGowan I, Cranston RD, Latkin C, et al.
Anal human papillomavirus and HIV: A cross-sectional study among men who have sex
with men in Moscow, Russia, 2012–2013. Euro surveillance : bulletin Europeen sur les
maladies transmissibles = European communicable disease bulletin 2015 Apr
16,;20(15):21095.
(30) Beer L, Mattson CL, Bradley H, Skarbinski J. Understanding Cross-Sectional
Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression
Among HIV Patients in the United States. Medicine 2016 Mar;95(13):e3171.
(31) Y. Omar Whiteside, Stacy M. Cohen, Heather Bradley, Jacek Skarbinski, H. Irene
Hall, Amy Lansky. Progress Along the Continuum of HIV Care Among Blacks with
Diagnosed HIV — United States, 2010. Morbidity and Mortality Weekly Report 2014
Feb 7,;63(5):85-89.
(32) Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL.
Gender Disparities in HIV Treatment Outcomes Following Release From Jail: Results
From a Multicenter Study. American journal of public health 2014 Mar;104(3):434-441.
(33) Weiser S, Frongillo E, Ragland K, Hogg R, Riley E, Bangsberg D. Food Insecurity
is Associated with Incomplete HIV RNA Suppression Among Homeless and Marginally
Housed HIV-infected Individuals in San Francisco. J GEN INTERN MED 2009
Jan;24(1):14-20.

98

(34) Wang E, McGinnis K, Fiellin D, Goulet J, Bryant K, Gibert C, et al. Food Insecurity
is Associated with Poor Virologic Response among HIV-Infected Patients Receiving
Antiretroviral Medications. J GEN INTERN MED 2011 Sep;26(9):1012-1018.
(35) Eholié S, Tanon A, Polneau S, Ouiminga M, Djadji A, Kangah-Koffi C, et al. Field
Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Adults in Abidjan,
Côte dʼIvoire. JAIDS Journal of Acquired Immune Deficiency Syndromes 2007 Jul
1,;45(3):355-358.
(36) Viswanathan S, Justice A, Alexander G, Brown T, Gandhi N, McNicholl I, et al.
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral
Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 2015 Aug
1,;69(4):493-498.
(37) Garson D. Multiple regression: 2014 edition (Statistical Associates Blue Book Series
6 [Kindle Edition]. 2014.
(38) Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression
model. Journal of Interdisciplinary Mathematics 2010 Jun 1,;13(3):253-267.

99

Tables
Table 1: Frequency Distribution for Viral Suppression Among the MASH
Cohort Retained Participants in Miami-Dade, FL from 2009-2014

Variable
Race/Ethnicity
White
Non-White
Gender
Male
Female
Age
≤25
26-34
35-44
≥45
Education
<HS
HS
>HS
AUDIT score
<8
≥8
Cocaine Use
Positive
Negative
Marijuana Use
Positive
Negative
Tobacco
Frequency
0=none
1=once in the last
30 days
2=once per week

Non-Viral
Suppressed
(n=26, 50.98%)

Virally
Suppressed
(n=25, 49.02%)

Chisquared/Fisher
exact Test
0.13

3 (27.27%)
23 (57.50%)

8(72.73%)
17 (42.50%)

20 (60.61%)
6 (33.33%)

13 (39.36%)
12 (66.67%)

0.11*

0.71
1 (100%)
2 (40.00%)
11 (57.89%)
12 (46.15%)

0 (0.00%)
3 (60.00%)
8 (42.11%)
14 (53.85%)
0.17

6 (40.00%)
12 (46.15%)
7 (77.78%)

9 (60.00%)
14 (53.85%)
2 (22.22%)
1.00*

17 (50.00%)
9 (52.94%)

17 (50.00%)
8 (47.06%)
1.00

5 (55.56%)
20 (48.78%)

4 (44.44%)
21 (51.22%)
0.29

7 (70.00%)
18 (45.00%)

3 (30.00%)
22 (55.00%)
0.33

13 (59.10%)

9 (40.90%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

100

3=3-4 times per
0 (0.00%)
1 (100.00%)
week
4=daily
0 (0.00%)
2 (100.00%)
5=Multiple times
13 (50.00%)
13 (50.00%)
per day
Depression
0.47
Positive (CES-D
25 (52.08%)
23 (47.92%)
score ≥16)
Negative (CES-D
1 (33.33%)
2 (66.67%)
score <16)
*Indicates Chi-squared test, otherwise Fisher exact test used
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Table 2: Adjusted Odds Ratio (AOR) for Viral Suppression Among the
MASH Cohort Retained Participants in Miami-Dade, FL from 2009-2014
Model 1
Variable

AOR

Model 2

95%CI

UOR

95%CI

0.46
Ref.

0.02–5.11

0.35
Ref.

0.06.–1.45

0.88
Ref.

0.27–2.87

0.76
Ref.

0.17–3.28

Depression
0.02–
12.81

CES-D Score ≥16
CES-D Score <15
Marijuana Use
Marijuana Use (+)
Marijuana Use (-)
AUDIT Score

0.66
Ref.

AUDIT Score≥8
AUDIT Score<8
Cocaine Use

0.56
Ref.

Cocaine (+)
Cocaine (-)
Education (yrs)

1.22
Ref.

Education
Age (yrs)

0.75

0.45–
1.14

0.75*

0.52–1.03

Age
Race/Ethnicity

1.02

0.94–
1.11

1.03

0.96–1.11

Non-White
White
Gender

0.21*
Ref.

0.28*
Ref.

0.05–1.12

0.33*
Ref.

0.09–1.05

1.09
Ref.

0.87–1.38

Male
Female
Tobacco
Frequency
Tobacco Use (1-5)
No Tobacco Use
**p-value≤0.05, *p≤0.10

0.30
Ref.

0.34
Ref.

0.0.–1.92

0.11–
2.50

0.18–
7.79

0.03–
1.10

0.05–
1.75

1.18
Ref.
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Supplemental Tables
Table 3: Frequency Distribution of Factors Among Virally Suppressed
and Not Virally Suppressed in the
MASH Cohort in Miami-Dade County from 2009-2012
(4-Day Adherence)
Number
of
Factors
One
Two
Three
Four
Five
Six
Missing

Frequency (%) of category
among Virally Suppressed

Frequency (%) of
category among
non-Virally
Suppressed

Total
Frequency
(%) overall

4 (7.84%)
7 (13.73%)
7 (13.73%)
5 (9.80%)
1 (1.96%)
1(1.96%)
0 (0.00%)

0.00%
6 (11.76%)
12 (23.53%)
5 (9.80)
1 (1.96%)
0 (0.00%)
2 (3.92%)

4 (7.84%)
13 (25.49%)
19 (37.26%)
10 (19.61%)
2 (3.92%)
1 (1.96%)
2 (3.92%)
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Table 4: Adjusted Odds Ratio for the Syndemic
Association with Viral Suppression in the
MASH Cohort in Miami-Dade County from
2009-2012
Variable
Number of Factors
Number of Factors
Age
Age
Race/Ethnicity
White
Non-White
Gender
Female Gender
Male Gender

AOR

95%CI

0.91 0.50–1.67
1.02 0.94–1.10
1.00
0.31 0.07–1.41
1.00
0.39 0.11–1.44
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Discussion
This dissertation sought to investigate the individual-level factors’ individual,
syndemic, and interactive associations with the multiple stages of the HIV care
continuum (retention, adherence, and viral suppression). We determined Non-Hispanic
Black race/ethnicity, Black-Hispanic, and Other racial/ethnic identities were associated
with increased retention among participants. This study supports previous literature
which suggests that Black race is associated with reduced odds of retention when
compared to other races/ethnicities and that Black Hispanic persons and persons of the
Other race/ethnic group have a higher odds of retention in HIV care than their NonHispanic White counterparts (1-3). Several mechanisms have been offered relating to
Black persons’ reduced retention in HIV care. They include factors related to access (i.e.
transportation and lack of qualified medical professionals within reachable distance) and
psychosocial factors (i.e. stigma and medical mistrust)(4).
The interaction between depression and alcohol use disorder was negatively
associated with retention. This negative interaction suggests that the negative impact of
depression on retention differs by alcohol dependence. Alcohol has been determined to
exacerbate the effect of depression among persons with HIV and increased depressive
symptoms have been shown to reduce retention (5,6). In addition, those who abuse
alcohol are at increased risk for major depression, and depression is associated with
reduced retention (6,7). Recent research related to the direction of causality between
alcohol use and depressive symptoms provides inconsistent results (7,8).
The interaction between age and male gender is also negatively associated with
retention. The literature supports the notion that both male gender and increased age
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reduce retention in care (9,10). This suggests that the negative impact of male gender on
retention may be influenced by increased age (or equivalently the effect of age on
retention varies by male gender). The interaction between depression and male gender
yielded a positive association with retention. While both male gender and depression
have been indicated to reduce retention in care among HIV positive persons, some studies
indicate that there may be a higher odds of retention among males when compared to
females(9-11).
The stratified analysis suggested that among those who are depressed, NonHispanic Blacks have a lower likelihood of being retained in care compared to the White
non-Hispanic reference group than do their Black-Hispanic and Other racial/ethnic
counterparts. This trend is consistent with the current literature (12,13). The reduced
association of Non-Hispanic Black race/ethnicity with retention may be related to stigma
within the Black community related to HIV care (14). The increased odds of retention
among the Black Hispanic and other ethnic groups may be the result of bilingualism
among hospital staff in the Miami-Dade location. Previous literature suggests that
bilingual personnel in an HIV care facility increases clinical visits among Hispanic
persons with HIV (15). Given the large Hispanic population in Miami, bilingualism is
prevalent in most healthcare institutions.
In the second study, we assessed the frequency distributions of individual-level
factors and their associations with adherence. Persons between the ages of 35–44, WhiteHispanic persons, those without alcohol use disorder, and males had the highest
percentages of short term and long-term adherence. Hispanic persons tend to have a
similar adherence percentage to Non-Hispanic white persons and a higher percentage of
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adherence when compared to African Americans(16) The reason the White Hispanic
group had a higher percentage of adherence than the other groups in this study may be
due to bilingualism which has been evidenced to improve HIV care outcomes and is
generally prevalent in most Miami, Dade healthcare facilities (17). Persons who are
monolingual Spanish speakers are at increased risk for poorer HIV outcomes as the
linguistic barrier may make it difficult for these persons to understand healthcare
materials and instructions written in another language. Bilingual staff at healthcare
institutions are capable of addressing these issues(17,18). Males had a higher percentage
of both short term and long-term adherence than did females; this finding is corroborated
by current literature (19). Persons with high levels of adherence are older in most studies;
therefore, it is consistent with the literature that the youngest group (≤25) would not have
the highest percentage of adherence (20). However, we noticed that the eldest age group
(≥45), did not have the highest percentage of short term or long-term adherence. Some
literature does corroborate this finding as older patients with evidenced cognitive decline
are likely to have poorer adherence (21,22). The trend of increased percentages of
adherence among those who do not engage in alcohol abuse when compared to those who
do not is consistent with current literature (23). While these percentages are not
statistically significant, the tends determined in this study may aid researchers in
developing an integrative intervention framework.
This study presents evidence supporting the negative association between cocaine
use and short term adherence and is consistent with the general body of literature(24). A
possible mechanism for this association may be neurocognitive decline developed as a
result of both cocaine use and the HIV infection(25). Among those assessed for long term
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adherence, we found that increased education was negatively and significantly associated
with adherence. This finding is corroborated in the literature, indicating a statistically
significant negative relationship between adherence and years of education completed;
however, most literature which assesses the relationship between education and long term
adherence generally find that reduced levels of education are associated negatively with
long term retention (26,27). Studies have suggested a potential reason for the negative
association between years of education completed and adherence is fear of HIV stigma
among more educated persons, resulting in avoidance of HIV clinics and therefore less
consistent use of medication(28). However, upon distribution analysis, we determined
that a majority of persons with more than two years of education had alcohol use
disorder. After removing these individuals from this education category, education was
no longer associated with long term adherence. This finding suggests that a high
percentage of alcohol use disorder among the few persons with more than two years of
college in this sample (n= 10) may have been the cause of this association. These findings
suggest that a more comprehensive study of the effect of education on adherence is
warranted.
The final study assessed the association between individual-level factors and viral
suppression. This study suggests that Non-White race/ethnicity, education, and male
gender were marginally and negatively associated with viral suppression. Recent research
has suggested that this ethnic disparity related to viral suppression may be due to reduced
adherence as a result of medical mistrust, and differences in prescribed regimen or setting
(29). Scarce research exists regarding reasoning for the gender differences in viral
suppression and the majority of literature attributes these differences to other factors such
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as gender-specific differences in structural support and homelessness (30,31). Regarding
our findings related to education, similar negative, non-significant trends have been
reported in previous literature (32,33). Studies have suggested a potential reason for the
negative association between years of education completed and adherence is fear of HIV
stigma among more educated persons, resulting in avoidance of HIV clinics and therefore
less consistent use of medication(28). Less consistent use of medication would result in
reduced viral suppression(34). This association may be due to small cell sizes in this
sample only Those categories of six, seven, and eight years of education only had one
person per category. These small cell sizes can alter an association(35). After removing
these educational categories, education was no longer associated with viral suppression.
More research is necessary to further explain this trend.
Researchers also determined the interaction between alcohol use disorder and
education was significantly and positively associated with viral suppression, suggesting
that the effect of alcohol use disorder on viral suppression varies according to education
level (or equivalently the effect of education on viral suppression varies by alcohol use
disorder status). An implication of this finding would be to develop more exploratory
studies to determine the rationale related to the interaction’s positive association with
viral suppression. Education may be a significant predictor of later viral suppression
because it is capturing the effect of adulthood resource disparities, which could have
long-lasting health consequences (26). This interaction was removed due to collinearity
(30).
Throughout each of the studies, we notice the association of race/ethnicity with
each progression to each stage in the continuum. These associations suggest the need for
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patient-centered care for Black persons and Non-White persons overall. Throughout the
studies we also notice White-Hispanics attaining increased odds and percentages of
retention and adherence. This finding may be supportive of the necessity of bilingualism
in HIV care. In the final two studies, gender played an important role. Males had a higher
percentage adherence, than did females, however, they had marginally significant lower
odds of achieving viral suppression. More research is necessary to understand this
occurrence. This finding may suggest that gender-specific assistance is necessary for the
adherence and viral suppression stages of the HIV care continuum. According to the
literature, improved supportive relationships may improve women’s adherence, while
improved health literacy could be beneficial in improving male viral suppression(29,36).
In the final two studies assessing adherence and viral suppression, persons with less than
a high school diploma had a higher percentage of adherent persons and a marginally
higher odds of viral suppression than their more educated counterparts. Some literature
has indicated that a potential reason for this is the fear of HIV stigma among more
educated persons(28). While no particular substance was present as a significant variable
at each stage of the HIV care continuum, the use of various substances (interactively or
individually) were negatively associated with different stages of the HIV care continuum.
In the first study, the alcohol use disorder*depression interaction was negatively
associated with retention. In the second study cocaine use was associated with reduced
short term adherence. Finally in the original analysis for the third manuscript, researchers
determined a negative association between the alcohol use disorder*education
interaction. These findings suggests that multiple substances may have deleterious

110

impacts on progression to different stages of the HIV care continuum and perhaps
substance use counseling may be a necessity for persons entering treatment for HIV care.
Researchers also determined multiple interactions associated with various stages
of the HIV care continuum, however, none were consistently associated with each stage
of the HIV care continuum. Each interaction provides evidence for clinical implications
of HIV care. The alcohol use disorder and depression interaction was significantly and
negatively associated with retention. This finding provides evidence for the necessity of
specialized care (counseling regarding alcohol use) for HIV positive persons who are
depressed. The age and male interaction, which was also significantly and negatively
associated with retention provides evidence for the necessity of specialized care among
older HIV positive males. The male gender and depression interaction, which was
positively associated with retention provides evidence for the necessity of patientcentered for HIV positive females who experience depressive symptoms. Although
removed due to collinearity within the model, the alcohol use disorder and education
interaction was positively associated with viral suppression. This provides evidence that
among persons with an alcohol use disorder, those with lower education may need
increased counseling related to viral suppression.
The syndemic associations were quite similar throughout the entire study. At each
stage in the continuum, the majority of persons who had attained a stage in the HIV care
continuum (i.e. retention, adherence, and viral suppression) were concentrated the two
and three factors category. This is significant because it suggests that most persons who
had progressed to each stage in the continuum had two to three vulnerability factors that
could affect their health outcomes. Assessing the number of vulnerability factors an HIV
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infected patient has could inform clinical practices and improve care for those with HIV.
Determining a threshold or index that predicts success along the HIV care continuum,
also may be useful
In sum, multiple races/ethnicities are positively associated with retention with
Non-Hispanic Black race/ethnicity having the smallest association. Multiple interactions
are associated with retention including depression*alcohol use disorder, age*male
gender, and depression*male gender. There are also differential effects of individuallevel factors on retention among stratified groups. Cocaine use is negatively significantly
associated with short term adherence, while Non-white race/ethnicity and male gender
are marginally associated with viral suppression. White Hispanic persons tend to have
higher frequencies of both adherence and viral suppression. Collectively these studies
suggests that substance use (either interactively or individually) negatively impact
progression to retention and adherence. Overall these studies also suggest differential
odds of progression to various HIV care continuum stages (retention and viral
suppression) by racial/ethnic group. Future research is necessary to further determine the
mechanism for the association between these individual level factors (ethnicity and
substance use) and progression to various stages in the HIV care continuum. In the
syndemic analysis for each stage of the HIV care continuum, all persons who progressed
to each stage had at least two to three factors that could affect their health outcomes.
Also, in the syndemic analysis, the number of factors was negatively associated with each
stage. Although these associations were not significant, these trends could inform clinical
practices and improve care for those with HIV.
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Conclusion
Collectively our study suggests that race/ethnicity, gender, alcohol use, substance use,
and depression are individually and interactively associated with various stages of the
HIV care continuum. Specifically, these findings suggest the negative association
between multiple factors and retention (i.e. depression*alcohol use disorder and
age*male gender). An implication of these findings is depression counseling for HIV
patients who suffer from alcohol abuse disorder and alcohol use disorder screening for
HIV patients who suffer from depression. Also, males may require patient coordinated
care to ensure retention as they age. Findings also suggest Non-Hispanic Black persons
may require improved patient care as the positive association between Non-Hispanic
Black race/ethnicity and retention was the lowest when compared to other
races/ethnicities. Due to small sample size, we were unable to find more specific
information related to these interactions, therefore future research should assess these
interactions with larger sample sizes. Cocaine use is negatively associated with short term
adherence and an implication would be to include substance counseling along with
adherence interventions among non-adherent persons with HIV infection. Future research
should assess mechanisms that cause cocaine to be deleterious to short term adherence
among PLWH. Other findings in this dissertation also indicated that male gender and
Non-White race/ethnicity are marginally associated with reduced viral suppression. This
suggests that future research should be focused on the mechanisms that cause this
association and a clinical implication is improved patient care among Non-White and
male PLWH. Throughout this dissertation race/ethnicity and gender were pertinent
factors. In these studies, we notice White-Hispanics attaining increased odds and
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percentages of retention and adherence. Further research should assess aspects of
acculturation that may be associated with retention and adherence among White Hispanic
persons. Males had a higher percentage adherence, than did females, however, they had
marginally significant lower odds of achieving viral suppression. Future research should
assess mechanisms responsible for gender differences in attaining various HIV care
continuum milestones. Syndemic analysis revealed at each stage of the continuum, the
majority of persons have two to three vulnerability factors that could alter their progress.
An implication of this finding would be an in-depth assessment of patient vulnerability
factors for the purpose of coordinating care specifically for each patient. This dissertation
emphasizes the need for multifaceted patient centered care among PLWH as these
persons are not unimodal, but rather have a multitude of factors that may affect their
progression to viral suppression.
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